王一濤

講座教授
院長,中華醫藥研究院
主任,中藥質量研究國家重點實驗室(澳門大學)
聯席主席兼常設秘書處秘書長,中華創新藥物聯合研究中心(北京大學、台灣大學、香港大學、澳門大學聯合建立)

 

學歷 | 主講科目 | 學術研究 | 科研論著 | 聯絡方法


學歷

  • 重慶醫科大學,藥理學研究生課程
  • 成都中醫藥大學,醫學學士

主講科目

  1. 中藥研究導論 (MCMC103)
  2. 醫藥管理研究導論 (MCMC110)

學術研究

研究方向

  • 中藥質量系統評價
  • 創新藥發現與開發
  • 醫藥管理研究

    王一濤講座教授多年來致力於中藥質量系統評價研究,將系統藥理學、分子藥劑學等現代生物醫藥前沿理念、方法和技術,融入中藥質量系統評價及其創新中藥研究開發,重點針對活血、清熱和扶正三類中藥,分別從質量物質基礎、質量評價方法和質量保障技術三個層次,進行中藥質量系統評價的關鍵環節和技術創新研究。先後主持和承擔了國家基礎研究計劃(973)、國家科技攻關計劃、國家自然科學基金重點項目、國家科技基礎性工作、香港創新科技署國際合作、澳門科學技術發展基金等30余項重點研究項目。

    近10年王一濤教授發表SCI收錄論文200余篇(h-index=31)、中文論文230余篇,出版學術專著16部(主編12部、副主編4部)。已培養畢業博士和碩士100餘名、博士後20余名。獲國務院授予政府特殊津貼專家(1993),國家科技進步獎(1998),國家知識產權傑出成就獎(1998),澳門特區政府教育功績勳章(2011),澳門特區政府首屆自然科學獎(2012)和第二屆自然科學獎(2014)等殊榮。

    王一濤教授1982年於成都中醫藥大學獲醫學學士學位;1986年於重慶醫科大學完成國家教育部藥理學研究生課程,隨後公派赴日研修,1989年歸國於成都中醫藥大學任教,歷任副教授、教授、藥學院院長、校長助理、副校長,成功申報并負責建設中國首個中藥學國家重點學科、首個中藥藥理學本科專業、首個中藥學博士後工作站、首個中藥學國家理科人才基地。1996年調京任中國中醫科學院副院長兼中藥研究所所長(世界衛生組織傳統醫學合作中心)。1997年參與籌備和申報國家重點基礎研究項目(973項目),1999年獲國家科技部批准為中國第一個中醫藥領域973項目,王一濤教授亦被聘為兩位973首席科學家之一。2000年被聘為首批中國中醫科學院首席研究員。2000年應邀赴香港科技大學任教授兼中藥學科研究主任,承擔國際合作項目“香港中藥標準與認證”研究。

    2002年王一濤教授應邀赴澳門大學,籌建大學第一個研究型學科——中華醫藥研究院。從舊學生宿舍改建起步,歷經師生十年艱苦創業,從無到有,形成博士、碩士和本科多層次創新人才培養體系,有生物醫藥、中藥學和醫藥管理三個專業,具有國際一流研究條件的研究型學科。研究院十分注重多學科協調創新能力和國際拓展能力的培養,極為重視與國際頂尖學術機構的聯合培養與合作研究,已與劍橋、耶魯、哈佛和芝加哥等著名大學,以及世界衛生組織、美國藥典會、中科院上海藥物所等著名學術機構,建立了聯合培養、資源共享和學術研究的戰略合作關係。十年來,研究院陸續從全球公開招聘了29位博士,他們多有哈佛、劍橋、耶魯、斯坦福、愛丁堡、北大、台大、港大和美國國立衛生研究院等著名學府的學術經歷,來澳大后都取得了驕人的學術業績。研究院已經為澳門和海內外輸送了300餘名優異博碩士高端人才,學術研究水平和國際聲譽不斷攀升。

    2008年王一濤教授會同本澳專家向國家科技部申報籌建中藥國家重點實驗室,在澳門科技發展基金扶助下,經兩年精心籌建, 2010年國家科技部正式批准在澳門設立中藥質量研究國家重點實驗室,成為中國第一個中醫藥領域的國家重點實驗室。在王一濤教授倡議下,經北京大學、台灣大學、香港大學和澳門大學的共同努力,2012年共同創立了“中華創新藥物聯合研究中心”,這是大中華四地頂尖大學共建的第一個科技共同體,澳大作為中心的合作研發基地和常設秘書處,將為海內外科學家和醫藥企業在創新醫藥領域的合作,提供優質技術服務和一流研發平臺。

    王一濤教授現任澳門大學講座教授,中華醫藥研究院院長,中藥質量研究國家重點實驗室(澳門大學)主任,中華創新藥物聯合研究中心聯席主任兼秘書長,北京大學國際醫藥管理研究中心主任,國際中醫藥學會秘書長,世界中醫藥學會聯合會常務理事兼副秘書長。被海內外多所知名大學聘為榮譽教授、特聘教授或客座教授;被聘為國家科技計畫、國家科技進步獎勵、國家藥品審評、國家自然科學基金等審評專家。


科研論著

 

Book chapters / Monographs

  1. Advances in Chinese Medicinal Approach to Cancer. Beijing: People’s Medical Publishing House,2012, ISBN 9787117162272, 7117162279. Chief Editor.
  2. Chromatographic Analysis of Commonly Used Chinese Material Medica, Macao: University of Macau Press, 2009, ISBN 978-99937-970-6-7. Co-Chief Editor.
  3. Pharmacological Activity-Based Quality Control of Chinese Herbs, Nova Science Publishers, Inc, 2008, ISBN-10: 1-60456-823-2. Co-Chief Editor.
  4. Chinese Medical Sciences collection Series (A)–Progress in Medicinal Administration Research. Macao: University of Macau Press, 2005, ISBN 99937-26-50-8. Chief Editor.
  5. Chinese Medical Sciences collection Series (B)–Progress in Traditional Chinese Medical Research. Macao: University of Macau Press, 2005, ISBN 99937-26-51-6. Chief Editor.
  6. Chinese Medical Sciences collection Series (C) – Quality Evaluation for Chinese Medicine 1. Macao: University of Macau Press, 2005, ISBN 99937-26-52-4. Chief Editor.
  7. Chinese Medical Sciences collection Series (C) – Quality Evaluation for Chinese Medicine 2. Macao: University of Macau Press, 2005, ISBN 99937-26-53-2. Chief Editor.
  8. Chinese Medical Sciences collection Series (C) – Quality Evaluation for Chinese Medicine 3. Macao: University of Macau Press, 2005, ISBN 99937-26-54-0. Chief Editor.
  9. Chinese Medical Sciences collection Series (C) – Quality Evaluation for Chinese Medicine 4. Macao: University of Macau Press, 2005, ISBN 99937-26-55-9. Chief Editor.
  10. Chinese Medical Sciences collection Series (C) – Quality Evaluation for Chinese Medicine 5. Macao: University of Macau Press, 2005, ISBN 99937-26-56-7. Chief Editor.
  11. Chinese Medical Sciences collection Series (C) – Quality Evaluation for Chinese Medicine 6. Macao: University of Macau Press, 2005, ISBN 99937-26-57-5. Chief Editor.
  12. Chinese Terms in Chinese Medicine and Pharmacy. Beijing: Science Press, 2005, ISBN 7-03-015154-2, Associate Editor.
  13. Intellectual Propert Protection of TCM. Beijing: China Press of TCM, 2003, ISBN 7-80-15641-89, Chief Editor.
  14. Drug Administration of European Union and Traditional Chinese Medicine. China International Culture Press Limited, 1999, Associate Editor.
  15. Tranditional Chinese Medicine pharmacology and application. Beijing: People’s Medical Publishing House, 1997, ISBN 7-117-03057-7/R.3058, Associate Editor.
  16. New product development from Tranditional Chinese Medicine. Beijing: People’s Medical Publishing House, 1997, ISBN 7-117-02640-5, Chief Editor.

International peer-reviewed journals / Science Citation Index-included (* denotes corresponding author)

  1. Zou LD, Chen FQ, Bao JL, Wang SP, Wang L, Chen MW, He CW, Wang YT. Preparation, characterization, and anticancer efficacy of evodiamine-loaded PLGA nanoparticles. Drug Delivery. In press. (IF=2.202)
  2. Zhang JM, Li YB, Gao W, Repka MA, Wang YT*, Chen MW. Andrographolide-loaded PLGA-PEG-PLGA micelles to improve its bioavailability and anticancer efficacy. Expert Opinion on Drug Delivery. In press. (IF=4.116)
  3. Wang L, Li HT, Wang SP, Liu R, Wu ZS, Wang CM, Wang YT, Chen MW. Enhancing the Antitumor Activity of Berberine Hydrochloride by Solid Lipid Nanoparticle Encapsulation. AAPS PharmSciTech. In press. (IF=1.776)
  4. Pratheeshkumar P, Son YO, Wang X, Divya SP, Joseph B, Hitron JA, Wang L, Kim D, Yin Y, Roy RV, Lu J, Zhang Z, Wang YT, Shi X. Cyanidin-3-Glucoside inhibits UVB-induced oxidative damage and inflammation by regulating MAP kinase and NF-kappaB signalling pathways in SKH-1 hairless mice skin. Toxicology and Applied Pharmacology. In press. (IF=3.630)
  5. Li XW, Yang Y, Henry RJ, Rossetto M, Wang YT*, Chen SL. Plant DNA barcoding: From gene to genome. Biological Reviews. In press. (IF=9.790)
  6. Guo JJ, Pan W, Chen MW, Wang CM, Wang YT*. Overview of Taiwan's indigenous ethnopharmacology in the perspective of traditional knowledge protection. Chinese Journal of Integrative Medicine. In press. (IF=1.401)
  7. Chen RE, Wang SP, Zhang JM, Chen MW, Wang YT*. Aloe-emodin loaded solid lipid nanoparticles: formulation design and in vitro anti-cancer study. Drug Delivery. In press. (IF=2.202)
  8. Zhu HL, Wan JB, Wang YT, Li BC, Xiang C, He J, Li P. Medicinal compounds with antiepileptic/anticonvulsant activities. Epilepsia. 2014, 55(1): 3-16. (IF=4.584)
  9. Zhong ZF, Tan W, Chen XP, Wang YT*. Furanodiene, a natural small molecule suppresses metastatic breast cancer cell migration and invasion in vitro. European Journal of Pharmacology. 2014, 737: 1-10. (IF=2.684)
  10. Zhang XJ, Su HX, He CW, Wang YT, Yang FQ, Wan JB. Discrimination of Pterocephalus hookeri collected at flowering and non-flowering stages using GC-MS-based fatty acid profiling. Analytical Methods. 2014, 6(7): 2141-2149. (IF=1.938)
  11. Yuan YF, Song YL, Jing WH, Wang YT, Yang XY, Liu DY. Simultaneous determination of caffeine, gallic acid, theanine, (-)-epigallocatechin and (-)-epigallocatechin-3-gallate in green tea using quantitative H-1-NMR spectroscopy. Analytical Methods. 2014, 6(3): 907-914. (IF=1.938)
  12. Yan ZX, Lin G, Yec Y, Wang YT, Yan R. Triterpenoid saponins profiling by adducts-targeted neutral loss triggered enhanced resolution and product ion scanning using triple quadrupole linear ion trap mass spectrometry. Analytica Chimica Acta. 2014, 819: 56-64. (IF=4.517)
  13. Yan ZX, Lin G, Ye Y, Wang YT, Yan R. A Generic Multiple Reaction Monitoring Based Approach for Plant Flavonoids Profiling Using a Triple Quadrupole Linear Ion Trap Mass Spectrometry. Journal of the American Society for Mass Spectrometry. 2014, 25(6): 955-965. (IF=3.193)
  14. Xu WS, Li T, Wu GS, Dang YY, Hao WH, Chen XP, Lu JJ, Wang YT*. Effects of Furanodiene on 95-D Lung Cancer Cells: Apoptosis, Autophagy and G1 Phase Cell Cycle Arrest. American Journal of Chinese Medicine. 2014, 42(1): 243-255. (IF=2.625)
  15. Xu WS, Dang YY, Chen XP, Lu JJ, Wang YT*. Furanodiene Presents Synergistic Anti-proliferative Activity With Paclitaxel Via Altering Cell Cycle and Integrin Signaling in 95-D Lung Cancer Cells. Phytotherapy Research. 2014, 28(2): 296-299. (IF=2.397)
  16. Xu JC, Kong XJ, Qiu L, Geng XM, Hu YJ, Wang YT*. Research and development of anti-Alzheimer's drugs: an analysis based on technology flows measured by patent citations. Expert Opinion on Therapeutic Patents. 2014, 24(7): 791-800. (IF=3.441)
  17. Xiang C, Li F, Zhang LD, Li BC, He J, Qin Y, Wan JB, Wang YT, Li P. Determination of radical scavengers from Salvia plants by HPLC. Analytical Letters. 2014, 47(1): 1-13. (IF=0.982)
  18. Wu WJ, Yan R, Yao MC, Zhan Y, Wang YT. Pharmacokinetics of anthraquinones in rat plasma after oral administration of a rhubarb extract. Biomedical Chromatography. 2014, 28(4): 564-572. (IF=1.662)
  19. Wu WJ, Hu N, Zhang QW, Li YP, Li P, Yan R, Wang YT. In vitro glucuronidation of five rhubarb anthraquinones by intestinal and liver microsomes from humans and rats. Chemico-Biological Interactions. 2014, 219: 18-27. (IF=2.982)
  20. Wang SP, Wang L, Shi Z, Zhong ZF, Chen MW, Wang YT*. Evodiamine Synergizes with Doxorubicin in the Treatment of Chemoresistant Human Breast Cancer without Inhibiting P-Glycoprotein. Plos One. 2014, 9(5): e97512. (IF=3.534)
  21. Wang L, Wang SP, Chen RE, Wang YP, Li H, Wang YT, Chen MW. Oridonin Loaded Solid Lipid Nanoparticles Enhanced Antitumor Activity in MCF-7 Cells. Journal of Nanomaterials. 2014: 903646. (IF=1.611)
  22. Tang ZH, Li T, Gao HW, Sun W, Chen XP, Wang YT, Lu JJ. Platycodin D from Platycodonis Radix enhances the anti-proliferative effects of doxorubicin on breast cancer MCF-7 and MDA-MB-231 cells. Chinese Medicine. 2014, 9: 16. (IF=2.343)
  23. Song YL, Yan HX, Chen JF, Wang YT, Jiang Y, Tu PF. Characterization of in vitro and in vivo metabolites of carnosic acid, a natural antioxidant, by high performance liquid chromatography coupled with tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 2014, 89: 183-196. (IF=2.829)
  24. Song YL, Jing WH, Yang FQ, Shi Z, Yao MC, Yan R, Wang YT*. Simultaneously enantiospecific determination of (+)-trans-khellactone, (+/-)-praeruptorin A, (+/-)-praeruptorin B, (+)-praeruptorin E, and their metabolites, (+/-)-cis-khellactone, in rat plasma using online solid phase extraction-chiral LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 2014, 88: 269-277. (IF=2.829)
  25. Song YL, Jing WH, Yan R, Wang YT*. Metabolic characterization of (+/-)-praeruptorin A in vitro and in vivo by high performance liquid chromatography coupled with hybrid triple quadrupole-linear ion trap mass spectrometry and time-of-flight mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 2014, 90: 98-110. (IF=2.829)
  26. Song YL, Jing WH, Yan R, Wang YT*. A pretreatment free method for the determination of seven natural products in a high-salt matrix by online guard column extraction coupled with tandem mass spectrometry. Analytical Methods. 2014, 6(2): 623-628. (IF=1.938)
  27. Song YL, Jing WH, Tu PF, Wang YT*. Development of enantiospecific and chemoselective methods for the determination of praeruptorin A enantiomers and their metabolites in rat plasma using chiral and achiral LC-MS/MS. Analytical Methods. 2014, 6(13): 4831-4839. (IF=1.938)
  28. Song YL, Jing WH, Tu PF, Wang YT*. Enantiomeric separation of angular-type pyranocoumarins from Peucedani Radix using AD-RH chiral column. Natural Product Research. 2014, 28(8): 545-550. (IF=1.225)
  29. Song YL, Jing WH, Du G, Yang FQ, Yan R, Wang YT*. Qualitative analysis and enantiospecific determination of angular-type pyranocoumarins in Peucedani Radix using achiral and chiral liquid chromatography coupled with tandem mass spectrometry. Journal of Chromatography A. 2014, 1338: 24-37. (IF=4.258)
  30. Song YL, Jing WH, Chen YG, Yuan YF, Yan R, Wang YT*. 1H nuclear magnetic resonance based-metabolomic characterization of Peucedani Radix and simultaneous determination of praeruptorin A and praeruptorin B. Journal of Pharmaceutical and Biomedical Analysis. 2014, 93: 86-94. (IF=2.829)
  31. Song YL, Jing WH, Tu PF, Wang YT*. Characterization of Peucedani Radix extract-derived angular-type pyranocoumarins in rats using ultra-high performance liquid chromatography coupled with hybrid triple quadrupole-linear ion trap mass spectrometry. Analytical Methods. 2014, 6(14): 5198-5206. (IF=1.938)
  32. Song J, Wang YC, Song YL, Chan H, Bi C, Yang X, Yan R, Wang YT, Zheng Y. Development and Characterisation of Ursolic Acid Nanocrystals Without Stabiliser Having Improved Dissolution Rate and In Vitro Anticancer Activity. AAPS Pharmscitech. 2014, 15(1): 11-19. (IF=1.776)
  33. Shen DY, Wei JC, Wan JB, Huang XJ, Xiang C, Li BC, Zhang QW, Wang YT, Li P. Four new C21 steroidal glycosides from Cynanchum otophyllum Schneid. Phytochemistry Letters. 2014, 9(1): 86-91. (IF=1.542)
  34. Qiu L, Chen ZY, Lu DY, Hu H, Wang YT*. Public funding and private investment for R&D: a survey in China's pharmaceutical industry. Health Research Policy and Systems. 2014, 12: 27. (IF=1.860)
  35. Niu YM, Bai J, Kamm RD, Wang YT, Wang CM. Validating antimetastatic effects of natural products in an engineered microfluidic platform mimicking tumor microenvironment. Molecular Pharmaceutics. 2014, 11(7): 2022-2029. (IF=4.787)
  36. Ni JY, Xu JC, Hu YJ, Su L, Wang YT. Cross-regional Pharmaceutical Technology Transfer in China Patterns and Proposed Investment Strategies. Therapeutic Innovation & Regulatory Science. 2014, 48(2): 226-235.
  37. Ma ZQ, Hu H, He TT, Guo H, Zhang MY, Chen MW, Wang YT. An assessment of traditional Uighur medicine in current Xinjiang region (China). African Journal of Traditional Complementary and Alternative Medicines. 2014, 11(2): 301-314. (IF=0.560)
  38. Liu LJ, Leung KH, Chan DSH, Wang YT, Ma DL, Leung CH. Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening. Cell Death and Disease. 2014, 5(6): e1293. (IF=5.177)
  39. Liu JJ, Wang YT*, Qiu L, Yu YY, Wang CM. Saponins of Panax notoginseng: chemistry, cellular targets and therapeutic opportunities in cardiovascular diseases. Expert Opinion on Investigational Drugs. 2014, 23(4): 523-539. (IF=5.432)
  40. Lin LG, Xie H, Wang YT, Ding J, Ye Y. Chemical Constituents from the Heartwood of Haematoxylon campechianum as Protein Tyrosine Kinase Inhibitors. Chemistry & Biodiversity. 2014, 11(5): 776-783. (IF=1.795)
  41. Li T, Xu WS, Wu GS, Chen XP, Wang YT*, Lu JJ. Platycodin D Induces Apoptosis, and Inhibits Adhesion, Migration and Invasion in HepG2 Hepatocellular Carcinoma Cells. Asian Pacific Journal of Cancer Prevention. 2014, 15(4): 1745-1749. (IF=1.500)
  42. Hu N, Mei M, Ruan JQ, Wu WJ, Wang YT, Yan R. Regioselective Glucuronidation of Oxyresveratrol, a Natural Hydroxystilbene, by Human Liver and Intestinal Microsomes and Recombinant UGTs. Drug Metabolism and Pharmacokinetics. 2014, 29(3): 229-236. (IF=2.863)
  43. Chen YG, Song YL, Wang Y, Yuan YF, Huang XJ, Ye WC, Wang YT, Zhang QW. Metabolic differentiations of Pueraria lobata and Pueraria thomsonii using H-1 NMR spectroscopy and multivariate statistical analysis. Journal of Pharmaceutical and Biomedical Analysis. 2014, 93: 51-58. (IF=2.829)
  44. Chen XP, Guo JJ, Bao JL, Lu JJ, Wang YT. The Anticancer Properties of Salvia Miltiorrhiza Bunge (Danshen): A Systematic Review. Medicinal Research Reviews. 2014, 34(4): 768-794. (IF=8.131)
  45. Chen RE, Zhang JM, Hu YY, Wang SP, Chen MW, Wang YT*. Potential Antineoplastic Effects of Aloe-emodin: A Comprehensive Review. American Journal of Chinese Medicine. 2014, 42(2): 275-288. (IF=2.625)
  46. Qiu L, Yu YY, Liu JJ, Hu H, Wang YT. For-profit medical institutions in China: Current status analysis and comparison with non-profit ones. Journal of Pharmaceutical Health Services Research. 2014, 5(1): 37-47.
  47. Chen MW, Chen WR, Zhang JM, Long XY, Wang YT*. Lobelia chinensis: chemical constituents and anticancer activity perspective. Chinese Journal of Natural Medicines. 2014, 12(2): 103-107.
  48. Ding RB, Bao JL, Cao YW, He CW, Wang YT, Wan JB. Panax notoginseng saponins protect against chronic ethanol-induced hepatic steatosis. Journal of Chinese Pharmaceutical Sciences. 2014, 23(6): 361-368.
  49. Zhao HY, Hu H, Wang YT. Comparative metabolism and stability of andrographolide in liver microsomes from humans, dogs and rats using ultra-performance liquid chromatography coupled with triple-quadrupole and Fourier transform ion cyclotron resonance mass spectrometry. Rapid Communications in Mass Spectrometry. 2013, 27(12): 1385-1392. (IF=2.642)
  50. Zhang XJ, Huang LL, Cai XJ, Li P, Wang YT*, Wan JB. Fatty acid variability in three medicinal herbs of Panax species. Chemistry Central Journal. 2013, 7: 12. (IF=1.663)
  51. Yao XL, Ye CH, Liu Q, Wan JB, Zhen J, Xiang AP, Li WQ, Wang YT, Su HX, Lu XL. Motoneuron Differentiation of Induced Pluripotent Stem Cells from SOD1G93A Mice. Plos One. 2013, 8(5): e64720. (IF=3.534)
  52. Xu ZT, Wu GS, Wei X, Chen XP, Wang YT*, Chen LD. Celastrol Induced DNA Damage, Cell Cycle Arrest, and Apoptosis in Human Rheumatoid Fibroblast-Like Synovial Cells. American Journal of Chinese Medicine. 2013, 41(3): 615-628. (IF=2.625)
  53. Wu GS, Song YL, Yin ZQ, Guo JJ, Wang SP, Zhao WW, Chen XP, Zhang QW, Lu JJ, Wang YT*. Ganoderiol A-Enriched Extract Suppresses Migration and Adhesion of MDA-MB-231 Cells by Inhibiting FAK-SRC-Paxillin Cascade Pathway. Plos One. 2013, 8(10): e76620. (IF=3.534)
  54. Wu GS, Lu JJ, Guo JJ, Huang MQ, Gan L, Chen XP, Wang YT*. Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells. Pharmacological Reports. 2013, 65(2): 453-459. (IF=2.165)
  55. Wu GS, Guo JJ, Bao JL, Li XW, Chen XP, Lu JJ, Wang YT*. Anti-cancer properties of triterpenoids isolated from Ganoderma lucidum - a review. Expert Opinion on Investigational Drugs. 2013, 22(8): 981-992. (IF=5.432)
  56. Wang SP, Zhong ZF, Wan JB, Tan W, Wu GS, Chen MW, Wang YT*. Oridonin Induces Apoptosis, Inhibits Migration and Invasion on Highly-Metastatic Human Breast Cancer Cells. American Journal of Chinese Medicine. 2013, 41(1): 177-196. (IF=2.625)
  57. Wang SP, Zhang JM, Chen MW, Wang YT*. Delivering flavonoids into solid tumors using nanotechnologies. Expert Opinion on Drug Delivery. 2013, 10(10): 1411-1428. (IF=4.116)
  58. Wang L, Zhang JM, Hong YL, Feng Y, Chen MW, Wang YT. Phytochemical and Pharmacological Review of Da Chuanxiong Formula: A Famous Herb Pair Composed of Chuanxiong Rhizoma and Gastrodiae Rhizoma for Headache. Evidence-Based Complementary and Alternative Medicine. 2013: 425369. (IF=2.175)
  59. Wan JB, Li P, Yang RL, Zhang QW, Wang YT. Separation and purification of 5 saponins from Panax notoginseng by preparative high-performance liquid chromatography. Journal of Liquid Chromatography & Related Technologies. 2013, 36(3): 406-417. (IF=0.638)
  60. Wan JB, Bai X, Cai XJ, Rao Y, Wang YS, Wang YT*. Chemical differentiation of Da-Cheng-Qi-Tang, a Chinese medicine formula, prepared by traditional and modern decoction methods using UPLC/Q-TOFMS-based metabolomics approach. Journal of Pharmaceutical and Biomedical Analysis. 2013, 83: 34-42. (IF=2.829)
  61. Su HX, Wang LH, Huang WH, Qin DJ, Cai JL, Yao XL, Feng CQ, Li ZY, Wang YT, So KF, Pan GJ, Wu WT, Pei DQ. Immediate expression of Cdh2 is essential for efficient neural differentiation of mouse induced pluripotent stem cells. Stem Cell Research. 2013, 10(3): 338-348. (IF=3.912)
  62. Su HX, Wang LH, Cai JL, Yuan QJ, Yang XY, Yao XL, Wong WM, Huang WH, Li ZY, Wan JB, Wang YT, Pei DQ, So KF, Qin DJ, Wu WT. Transplanted motoneurons derived from human induced pluripotent stem cells form functional connections with target muscle. Stem Cell Research. 2013, 11(1): 529-539. (IF=3.912)
  63. Shen H, Leung WI, Ruan JQ, Li SL, Lei JPC, Wang YT, Yan R. Biotransformation of ginsenoside Rb1 via the gypenoside pathway by human gut bacteria. Chinese Medicine. 2013, 8: 22. (IF=2.343)
  64. Lu JJ, Bao JL, Wu GS, Xu WS, Huang MQ, Chen XP, Wang YT*. Quinones Derived from Plant Secondary Metabolites as Anti-cancer Agents. Anti-Cancer Agents in Medicinal Chemistry. 2013, 13(3): 456-463. (IF=2.939)
  65. Li YB, Zhong ZF, Chen MW, Bao JL, Wu GS, Zhang QW, Lee SMY, Hoi PM, Wang YT*. Bisdemethoxycurcumin Increases Sirt1 to Antagonize t-BHP-Induced Premature Senescence in WI38 Fibroblast Cells. Evidence-Based Complementary and Alternative Medicine. 2013: 851714. (IF=2.175)
  66. Li YB, Wang ZQ, Yan X, Chen MW, Bao JL, Wu GS, Ge ZM, Zhou DM, Wang YT*, Li RT. IC-4, a new irreversible EGFR inhibitor, exhibits prominent anti-tumor and anti-angiogenesis activities. Cancer Letters. 2013, 340(1): 88-96. (IF=5.016)
  67. Li YB, Gao JL, Zhong ZF, Hoi PM, Lee SMY, Wang YT*. Bisdemethoxycurcumin suppresses MCF-7 cells proliferation by inducing ROS accumulation and modulating senescence-related pathways. Pharmacological Reports. 2013, 65(3): 700-709. (IF=2.165)
  68. Jing WH, Song YL, Yan R, Wang YT. Identification of cytochrome P450 isoenzymes involved in metabolism of (+)-praeruptorin A, a calcium channel blocker, by human liver microsomes using ultra high-performance liquid chromatography coupled with tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 2013, 77: 175-188. (IF=2.829)
  69. Huang L, Wu Q, Li YH, Wang YT, Bi HC. PXR-Mediated Upregulation of CYP3A Expression by Herb Compound Praeruptorin C from Peucedanum praeruptorum Dunn. Evidence-Based Complementary and Alternative Medicine. 2013: 156574. (IF=2.175)
  70. Huang L, Huang M, Li YH, Li RM, Zeng Y, Kuang SY, Zhang L, Wang YT, Bi HC. Up-regulatation of CYP3A expression through pregnent X receptor by praeruptorin D isolated from Peucedanum praeruptorum Dunn. Journal of Ethnopharmacology. 2013, 148(2): 596-602. (IF=2.939)
  71. Huang L, Bi HC, Li YH, Zhang JQ, Kuang SY, Zhang L, Wang YT, Huang M. Regulation of Human Pregnane X Receptor and its Target Gene Cytochrome P450 3A by Praeruptorin A Isolated from the Herbal Medicine Peucedanum praeruptorum. Planta Medica. 2013, 79(16): 1509-1515. (IF=2.339)
  72. Hu YY, Wang SP, Wu X, Zhang JM, Chen R, Chen MW, Wang YT*. Chinese herbal medicine-derived compounds for cancer therapy: A focus on hepatocellular carcinoma. Journal of Ethnopharmacology. 2013, 149(3): 601-612. (IF=2.939)
  73. Hu YJ, Scherngell T, Man SN, Wang YT*. Is the United States Still Dominant in the Global Pharmaceutical Innovation Network? Plos One. 2013, 8(11): e77247. (IF=3.534)
  74. Han W, Wang SP, Liang RX, Wang L, Chen MW, Li H, Wang YT. Non-ionic surfactant vesicles simultaneously enhance antitumor activity and reduce the toxicity of cantharidin. International Journal of Nanomedicine. 2013, 8: 2187-2196. (IF=4.195)
  75. Guo Y, Hu YJ, Zheng ML, Wang YT. Patent indicators: a window to pharmaceutical market success. Expert Opinion on Therapeutic Patents. 2013, 23(7): 765-771. (IF=3.441)
  76. Gao L, Fang JS, Bai XY, Zhou D, Wang YT, Liu AL, Du GH. In silico Target Fishing for the Potential Targets and Molecular Mechanisms of Baicalein as an Antiparkinsonian Agent: Discovery of the Protective Effects on NMDA Receptor-Mediated Neurotoxicity. Chemical Biology & Drug Design. 2013, 81(6): 675-687. (IF=2.507)
  77. Chen XP, Lu JJ, Bao JL, Guo JJ, Shi JS, Wang YT*. Adiponectin: A biomarker for rheumatoid arthritis? Cytokine & Growth Factor Reviews. 2013, 24(1): 83-89. (IF=6.537)
  78. Chen MW, Zhang JM, Lai YF, Wang SP, Li P, Xiao J, Fu CM, Hu H, Wang YT*. Analysis of Pogostemon cablin from pharmaceutical research to market performances. Expert Opinion on Investigational Drugs. 2013, 22(2): 245-257. (IF=5.432)
  79. Chen MW, Chen RE, Wang SP, Tan W, Hu YY, Peng XS, Wang YT*. Chemical components, pharmacological properties, and nanoparticulate delivery systems of Brucea javanica. International Journal of Nanomedicine. 2013, 8: 85-92. (IF=4.195)
  80. Yu WP, Yu XW, Hu H, Duan GM, Liu Z, Wang YT. Use of hospital appointment registration systems in China: a survey study. Global journal of health science. 2013, 5(5): 193-201.
  81. Shi HH, Chen MW, Shi YZ, Hu H, Wang YT. Challenges and prospects for monoclonal antibodies in China. Journal of Commercial Biotechnology. 2013, 19(2): 49-55.
  82. Zhou RN, Song YL, Ruan JQ, Wang YT, Yan R. Pharmacokinetic Evidence on the Contribution of Intestinal Bacterial Conversion to Beneficial Effects of Astragaloside IV, a Marker Compound of Astragali Radix, in Traditional Oral Use of the Herb. Drug Metabolism and Pharmacokinetics. 2012, 27(6): 586-597. (IF=2.071)
  83. Zhong ZF, Li YB, Wang SP, Tan W, Chen XP, Chen MW, Wang YT*. Furanodiene enhances tamoxifen-induced growth inhibitory activity of ERa-positive breast cancer cells in a PPAR gamma independent manner. Journal of Cellular Biochemistry. 2012, 113(8): 2643-2651. (IF=3.062)
  84. Zhong ZF, Hoi PM, Wu GS, Xu ZT, Tan W, Chen XP, Cui L, Wu T, Wang YT*. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo. Journal of Ethnopharmacology. 2012, 141(2): 721-727. (IF=2.755)
  85. Zhong ZF, Dang YY, Yuan X, Guo W, Li YB, Tan W, Cui JR, Lu JJ, Zhang QW, Chen XP, Wang YT*. Furanodiene, a Natural Product, Inhibits Breast Cancer Growth Both in vitro and in vivo. Cellular Physiology and Biochemistry. 2012, 30(3): 778-790. (IF=3.415)
  86. Zhao BX, Wang Y, Zhang DM, Huang XJ, Bai LL, Yan Y, Chen JM, Lu TB, Wang YT, Zhang QW, Ye WC. Virosaines A and B, Two New Birdcage-Shaped Securinega Alkaloids with an Unprecedented Skeleton from Flueggea virosa. Organic Letters. 2012, 14(12): 3096-3099. (IF=6.142)
  87. Zhang H, Zhang QW, Wang L, Zhang XQ, Ye WC, Wang YT. Two new anthraquinone malonylglucosides from Polygonum cuspidatum. Natural Product Research. 2012, 26(14): 1323-1327. (IF=1.031)
  88. Yi Y, Zhang QW, Li SL, Wang Y, Ye WC, Zhao J, Wang YT. Simultaneous quantification of major flavonoids in "Bawanghua", the edible flower of Hylocereus undatus using pressurised liquid extraction and high performance liquid chromatography. Food Chemistry. 2012, 135(2): 528-533. (IF=3.334)
  89. Yang F, Zhou WL, Liu AL, Qin HL, Lee SMY, Wang YT, Du GH. The Protective Effect of 3-Deoxysappanchalcone on In Vitro Influenza Virus-induced Apoptosis and Inflammation. Planta Medica. 2012, 78(10): 968-973. (IF=2.348)
  90. Xu ZT, Chen XP, Fu S, Bao JL, Dang YY, Huang MQ, Chen LD, Wang YT*. Dehydrocorydaline Inhibits Breast Cancer Cells Proliferation by Inducing Apoptosis in MCF-7 Cells. American Journal of Chinese Medicine. 2012, 40(1): 177-185. (IF=2.281)
  91. Xu WS, Dang YY, Guo JJ, Wu GS, Lu JJ, Chen XP, Wang YT*. Furanodiene Induces Endoplasmic Reticulum Stress and Presents Antiproliferative Activities in Lung Cancer Cells. Evidence-Based Complementary and Alternative Medicine. 2012: 426521. (IF=1.722)
  92. Wu GS, Qian ZM, Guo JJ, Hu DJ, Bao JL, Xie J, Xu WS, Lu JJ, Chen XP, Wang YT*. Ganoderma lucidum Extract Induces G1 Cell Cycle Arrest, and Apoptosis in Human Breast Cancer Cells. American Journal of Chinese Medicine. 2012, 40(3): 631-642. (IF=2.281)
  93. Wu GS, Lu JJ, Guo JJ, Li YB, Tan W, Dang YY, Zhong ZF, Xu ZT, Chen XP, Wang YT*. Ganoderic acid DM, a natural triterpenoid, induces DNA damage, G1 cell cycle arrest and apoptosis in human breast cancer cells. Fitoterapia. 2012, 83(2): 408-414. (IF=2.231)
  94. Wang SP, Wu X, Tan M, Gong J, Tan W, Bian BL, Chen MW, Wang YT*. Fighting fire with fire: Poisonous Chinese herbal medicine for cancer therapy. Journal of Ethnopharmacology. 2012, 140(1): 33-45. (IF=2.755)
  95. Wang SP, Hu YY, Tan W, Wu X, Chen RE, Cao JL, Chen MW, Wang YT*. Compatibility art of traditional Chinese medicine: From the perspective of herb pairs. Journal of Ethnopharmacology. 2012, 143(2): 412-423. (IF=2.755)
  96. Wang SP, Chen TK, Chen RE, Hu YY, Chen MW, Wang YT*. Emodin loaded solid lipid nanoparticles: Preparation, characterization and antitumor activity studies. International Journal of Pharmaceutics. 2012, 430(1-2): 238-246. (IF=3.458)
  97. Wan JB, Zhang QW, Hong SJ, Li P, Li SP, Wang YT*. Chemical Investigation of Saponins in Different Parts of Panax notoginseng by Pressurized Liquid Extraction and Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry. Molecules. 2012, 17(5): 5836-5853. (IF=2.428)
  98. Song YL, Zhang QW, Li YP, Yan R, Wang YT*. Enantioseparation and Absolute Configuration Determination of Angular-Type Pyranocoumarins from Peucedani Radix Using Enzymatic Hydrolysis and Chiral HPLC-MS/MS Analysis. Molecules. 2012, 17(4): 4236-4251. (IF=2.428)
  99. Song YL, Jing WH, Zhao HY, Yan R, Li PT, Wang YT. Stereoselective metabolism of (±)-praeruptorin A, a calcium channel blocker from Peucedani Radix, in pooled liver microsomes of rats and humans. Xenobiotica. 2012, 42(3): 221-237. (IF=1.984)
  100. Mei M, Ruan JQ, Wu WJ, Zhou RN, Lei JPC, Zhao HY, Yan R, Wang YT. In Vitro Pharmacokinetic Characterization of Mulberroside A, the Main Polyhydroxylated Stilbene in Mulberry (Morus alba L.), and Its Bacterial Metabolite Oxyresveratrol in Traditional Oral Use. Journal of Agricultural and Food Chemistry. 2012, 60(9): 2299-2308. (IF=2.906)
  101. Lu JJ, Pan W, Hu YJ, Wang YT*. Multi-Target Drugs: The Trend of Drug Research and Development. Plos One. 2012, 7(6): e40262. (IF=3.730)
  102. Lu JJ, Dang YY, Huang M, Xu WS, Chen XP, Wang YT*. Anti-cancer properties of terpenoids isolated from Rhizoma Curcumae - A review. Journal of Ethnopharmacology. 2012, 143(2): 406-411. (IF=2.755)
  103. Lu JJ, Bao JL, Chen XP, Huang M, Wang YT*. Alkaloids Isolated from Natural Herbs as the Anticancer Agents. Evidence-Based Complementary and Alternative Medicine. 2012: 485042. (IF=1.722)
  104. Li F, Zhang LD, Li BC, Yang J, Yu H, Wan JB, Wang YT, Li P. Screening of free radical scavengers from Erigeron breviscapus using on-line HPLC-ABTS/DPPH based assay and mass spectrometer detection. Free Radical Research. 2012, 46(3): 286-294. (IF=3.279)
  105. Huang MQ, Xie YL, Chen LD, Chu KD, Wu SS, Lu JJ, Chen XP, Wang YT, Lai XP. Antidiabetic Effect of the Total Polyphenolic Acids Fraction from Salvia miltiorrhiza Bunge in Diabetic Rats. Phytotherapy Research. 2012, 26(6): 944-948. (IF=2.068)
  106. Huang M, Lu JJ, Huang MQ, Bao JL, Chen XP, Wang YT*. Terpenoids: natural products for cancer therapy. Expert Opinion on Investigational Drugs. 2012, 21(12): 1801-1818. (IF=4.744)
  107. Gong J, Chen MW, Zheng Y, Wang SP, Wang YT*. Polymeric micelles drug delivery system in oncology. Journal of Controlled Release. 2012, 159(3): 312-323. (IF=7.633)
  108. Du G, Xiao Y, Yang HR, Wang L, Song YL, Wang YT*. Rapid determination of pesticide residues in herbs using selective pressurized liquid extraction and fast gas chromatography coupled with mass spectrometry. Journal of Separation Science. 2012, 35(15): 1922-1932. (IF=2.591)
  109. Ding RB, Tian K, Huang LL, He CW, Jiang Y, Wang YT, Wan JB. Herbal medicines for the prevention of alcoholic liver disease: A review. Journal of Ethnopharmacology. 2012, 144(3): 457-465. (IF=2.755)
  110. Chen XP, Bao JL, Guo JJ, Ding Q, Lu JJ, Huang MQ, Wang YT. Biological activities and potential molecular targets of cucurbitacins: a focus on cancer. Anti-Cancer Drugs. 2012, 23(8): 777-787. (IF=2.232)
  111. Chen XJ, Zhao J, Wang YT, Huang LQ, Li SP. CE and CEC analysis of phytochemicals in herbal medicines. Electrophoresis. 2012, 33(1): 168-179. (IF=3.261)
  112. Chen XJ, Dinh NP, Zhao J, Wang YT, Li SP, Svec F. Effect of ion adsorption on CEC separation of small molecules using hypercrosslinked porous polymer monolithic capillary columns. Journal of Separation Science. 2012, 35(12): 1502-1505. (IF=2.591)
  113. Chen MW, Zhou YF, Huang JJ, Zhu P, Peng XS, Wang YT. Liposome-Based Delivery Systems in Plant Polysaccharides. Journal of Nanomaterials. 2012: 682545. (IF=1.547)
  114. Chen MW, Zhang JM, Yu SQ, Wang SP, Zhang ZJ, Chen JQ, Xiao J, Wang YT*. Anti-Lung-Cancer Activity and Liposome-Based Delivery Systems of beta-Elemene. Evidence-Based Complementary and Alternative Medicine. 2012: 259523. (IF=1.722)
  115. Lai YF, Lu JJ, Chen XP, Hu H, Wang YT*. Analysis of Anti-cancer Traditional Chinese Medicine Injections based on Market Performance. World Science and Technology - Modernization of Traditional Chinese Medicine and Materia Medica. 2012, 14(5): 1958-1962.
  116. Ge S, Cheong KL, Hu H, Wang YT. Provision and usage of medical services by community pharmacy: A comparative study of New York, Macao and Zhuhai (China). Canadian Social Science. 2012, 8(6): 11-17.
  117. Chen XP, Guo JJ, Bao JL, Xu WS, Huang YJ, Wang YT. Screening Neuroprotective Agents Through 4-hydroxynonenal, Ethanol, High Glucose, Homocysteine, Okadaic Acid, Rotenone, and Oxygen-Glucose Deprivation Induced PC12 Injury Models: A Review. Current Psychopharmacology. 2012, 1(1): 103-110.
  118. Zhong ZF, Chen XP, Tan W, Xu ZT, Zhou KY, Wu T, Cui L, Wang YT*. Germacrone inhibits the proliferation of breast cancer cell lines by inducing cell cycle arrest and promoting apoptosis. European Journal of Pharmacology. 2011, 667(1-3): 50-55. (IF=2.516)
  119. Yeh JC, Cindrova-Davies T, Belleri M, Morbidelli L, Miller N, Cho CWC, Chan K, Wang YT, Luo GA, Ziche M, Presta M, Charnock-Jones DS, Fan TP. The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo. Angiogenesis. 2011, 14(2): 187-197. (IF=6.063)
  120. .979)
  121. Xu ZT, Chen XP, Zhang QW, Chen LDA, Wang YT*. Corydalis yanhusuo WT Wang Extract Inhibits MCF-7 Cell Proliferation by Inducing Cell Cycle G2/M Arrest. American Journal of Chinese Medicine. 2011, 39(3): 579-586. (IF=1.979)
  122. Wang SP, Tan M, Zhong ZF, Chen MW, Wang YT*. Nanotechnologies for Curcumin: An Ancient Puzzler Meets Modern Solutions. Journal of Nanomaterials. 2011: 723178. (IF=1.376)
  123. Tan W, Li YB, Chen MW, Wang YT*. Berberine hydrochloride: anticancer activity and nanoparticulate delivery system. International Journal of Nanomedicine. 2011, 6: 1773-1777. (IF=3.130)
  124. Song YL, Yan R, Jing WH, Zhao HY, Wang YT*. Characterization of metabolism of (+)-praeruptorin B and (+)-praeruptorin E in human and rat liver microsomes by liquid chromatography coupled with ion trap mass spectrometry and time-of-flight mass spectrometry. Rapid Communications in Mass Spectrometry. 2011, 25(6): 719-730. (IF=2.790)
  125. Liu YH, Mo SL, Bi HC, Hu BF, Li CG, Wang YT, Huang L, Huang M, Duan W, Liu JP, Wei MQ, Zhou SF. Regulation of human pregnane X receptor and its target gene cytochrome P450 3A4 by Chinese herbal compounds and a molecular docking study. Xenobiotica. 2011, 41(4): 259-280. (IF=1.791)
  126. Li ZH, Alex D, Siu SO, Chu IK, Renn J, Winkler C, Lou S, Tsui SKW, Zhao HY, Yan WR, Mahady GB, Li GH, Kwan YW, Wang YT, Lee SMY. Combined in vivo imaging and omics approaches reveal metabolism of icaritin and its glycosides in zebrafish larvae. Molecular Biosystems. 2011, 7(7): 2128-2138. (IF=3.534)
  127. Li YB, Lin ZQ, Zhang ZJ, Wang MW, Zhang HA, Zhang Q, Lee SMY, Wang YT*, Hoi PM. Protective, Antioxidative and Antiapoptotic Effects of 2-Methoxy-6-Acetyl-7-Methyljuglone from Polygonum cuspidatum in PC12 Cells. Planta Medica. 2011, 77(4): 354-361. (IF=2.153)
  128. Li YB, Gao JL, Lee SMY, Zhang QW, Hoi PM, Wang YT*. Bisdemethoxycurcumin protects endothelial cells against t-BHP-induced cell damage by regulating the phosphorylation level of ERK1/2 and Akt. International Journal of Molecular Medicine. 2011, 27(2): 205-211. (IF=1.573)
  129. Li GH, Zhang QW, Wang L, Zhang XQ, Ye WC, Wang YT. New Isoflavone C-Glycosides from Pueraria lobata. Helvetica Chimica Acta. 2011, 94(3): 423-428. (IF=1.478)
  130. Jing WH, Song YL, Yan R, Bi HC, Li PT, Wang YT*. Transport and metabolism of (+/-)-praeruptorin A in Caco-2 cell monolayers. Xenobiotica. 2011, 41(1): 71-81. (IF=1.791)
  131. Huang L, Bi HC, Liu YH, Wang YT, Xue XP, Huang M. CAR-mediated Up-regulation of CYP3A4 Expression in LS174T Cells by Chinese Herbal Compounds. Drug Metabolism and Pharmacokinetics. 2011, 26(4): 331-340. (IF=2.321)
  132. He BC, Gao JL, Luo XJ, Luo JY, Shen JK, Wang LY, Zhou QX, Wang YT, Luu HH, Haydon RC, Wang CZ, Du W, Yuan CS, He TC, Zhang BQ. Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/beta-catenin signaling. International Journal of Oncology. 2011, 38(2): 437-445. (IF=2.399)
  133. Du G, Zhao HY, Song YL, Zhang QW, Wang YT*. Rapid simultaneous determination of isoflavones in Radix puerariae using high-performance liquid chromatography-triple quadrupole mass spectrometry with novel shell-type column. Journal of Separation Science. 2011, 34(19): 2576-2585. (IF=2.733)
  134. Du G, Song YL, Wang YT*. Rapid simultaneous determination of multiple pesticide residues in traditional Chinese medicines using programmed temperature vaporizer injection-fast gas chromatography coupled with mass spectrometry. Journal of Separation Science. 2011, 34(23): 3372-3382. (IF=2.733)
  135. Deng YH, Alex D, Huang HQ, Wang N, Yu N, Wang YT, Leung GPH, Lee SMY. Inhibition of TNF-α-mediated Endothelial Cell-Monocyte Cell Adhesion and Adhesion Molecules Expression by the Resveratrol Derivative, trans-3,5,4 '-Trimethoxystilbene. Phytotherapy Research. 2011, 25(3): 451-457. (IF=2.086)
  136. Cui W, Cui GZ, Li WM, Zhang ZJ, Hu SQ, Mak SH, Zhang H, Carlier PR, Choi CL, Wang YT, Lee SMY, Han YF. Bis(12)-hupyridone, a novel multifunctional dimer, promotes neuronal differentiation more potently than its monomeric natural analog huperzine A possibly through alpha7 nAChR. Brain Research. 2011, 1401: 10-17. (IF=2.728)
  137. Chen XP, Zhong ZF, Xu ZT, Chen LD, Wang YT*. No protective effect of curcumin on hydrogen peroxide-induced cytotoxicity in HepG2 cells. Pharmacological Reports. 2011, 63(3): 724-732. (IF=2.445)
  138. Chen XP, Xu ZT, Wang YT*. Recent advances in breast cancer metastasis suppressor 1. International Journal of Biological Markers. 2011, 26(1): 1-8. (IF=1.479)
  139. Chen XP, Wang YT*. Adiponectin and breast cancer. Medical Oncology. 2011, 28(4): 1288-1295. (IF=2.140)
  140. Chen XP, Pei LX, Zhong ZF, Guo JJ, Zhang QW, Wang YT*. Anti-tumor potential of ethanol extract of Curcuma phaeocaulis Valeton against breast cancer cells. Phytomedicine. 2011, 18(14): 1238-1243. (IF=3.268)
  141. Chen MW, Wang SP, Tan M, Wang YT*. Applications of Nanoparticles in Herbal Medicine: Zedoary Turmeric Oil and Its Active Compound beta-Elemene. American Journal of Chinese Medicine. 2011, 39(6): 1093-1102. (IF=1.979)
  142. Wang N, Wan JB, Chan SW, Deng YH, Yu N, Zhang QW, Wang YT, Lee SMY. Comparative study on saponin fractions from Panax notoginseng inhibiting inflammation-induced endothelial adhesion molecule expression and monocyte adhesion. Chinese Medicine. 2011, 6: 37.
  143. Tan W, Lu JJ, Huang MQ, Li YB, Chen MW, Wu GS, Gong J, Zhong ZF, Xu ZT, Dang YY, Guo JJ, Chen XP, Wang YT*. Anti-cancer natural products isolated from chinese medicinal herbs. Chinese Medicine. 2011, 6: 27.
  144. Chen MW, Zhong ZF, Tan W, Wang SP, Wang YT*. Recent advances in nanoparticle formulation of oleanolic acid. Chinese Medicine. 2011, 6: 20.
  145. Shi JM, Han WL, Ye WC, Chen XQ, Wang YT, Zhang QW. Phytochemical Investigation of Corydalis yanhusuo. Natural Product Research and Development. 2011, 23(4): 647-651.
  146. Chen MW, Tan W, Wang SP, Zhong ZF, Wang YT*. Advances in the nanoparticle drug delivery systems of silymarin. Journal of Chinese Pharmaceutical Sciences. 2011, 20(5): 442-446.
  147. Wan JB, Zhang QW, Hong SJ, Guan J, Ye WC, Li SP, Lee MYS, Wang YT*. 5,6-Didehydroginsenosides from the Roots of Panax notoginseng. Molecules. 2010, 15(11): 8169-8176. (IF=1.988)
  148. Ruan JQ, Leong WI, Yan R, Wang YT. Characterization of Metabolism and in Vitro Permeability Study of Notoginsenoside R1 from Radix Notoginseng. Journal of Agricultural and Food Chemistry. 2010, 58(9): 5770-5776. (IF=2.816)
  149. Qin XL, Bi HC, Wang XD, Li JL, Wang Y, Xue XP, Chen X, Wang CX, Xu LJ, Wang YT, Huang M. Mechanistic understanding of the different effects of Wuzhi Tablet (Schisandra sphenanthera extract) on the absorption and first-pass intestinal and hepatic metabolism of Tacrolimus (FK506). International Journal of Pharmaceutics. 2010, 389(1-2): 114-121. (IF=3.607)
  150. Liu AL, Yang F, Zhu MA, Zhou D, Lin M, Lee SMY, Wang YT, Du GH. In Vitro Anti-influenza Viral Activities of Stilbenoids from the Lianas of Gnetum pendulum. Planta Medica. 2010, 76(16): 1874-1876. (IF=2.369)
  151. Liang QY, Chow AHL, Wang YT, Tong HHY, Zheng Y. Removal of toxic aristolochic acid components from Aristolochia plants by supercritical fluid extraction. Separation and Purification Technology. 2010, 72(3): 269-274. (IF=2.775)
  152. Hu YM, Wang YT, Sze SCW, Tsang KW, Wong HK, Liu Q, Zhong LD, Tong Y. Identification of the major chemical constituents and their metabolites in rat plasma and various organs after oral administration of effective Erxian Decoction (EXD) fraction by liquid chromatography-mass spectrometry. Biomedical Chromatography. 2010, 24(5): 479-489. (IF=1.545)
  153. Du G, Zhao HY, Zhang QW, Li GH, Yang FQ, Wang Y, Li YC, Wang YT*. A rapid method for simultaneous determination of 14 phenolic compounds in Radix Puerariae using microwave-assisted extraction and ultra high performance liquid chromatography coupled with diode array detection and time-of-flight mass spectrometry. Journal of Chromatography A. 2010, 1217(5): 705-714. (IF=4.194)
  154. Dang YY, Li XC, Zhang QW, Li SP, Wang YT. Preparative isolation and purification of six volatile compounds from essential oil of Curcuma wenyujin using high-performance centrifugal partition chromatography. Journal of Separation Science. 2010, 33(11): 1658-1664. (IF=2.631)
  155. Chen XP, Zhong ZF, Xu ZT, Chen LD, Wang YT*. 2',7'-Dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: Forty years of application and controversy. Free Radical Research. 2010, 44(6): 587-604. (IF=2.805)
  156. Chen XJ, Yang FQ, Wang YT, Li SP. CE and CEC of nucleosides and nucleotides in food materials. Electrophoresis. 2010, 31(13): 2092-2105. (IF=3.569)
  157. Zhang HL, Zhang QW, Zhang XQ, Ye WC, Wang YT. Chemical Constituents from the Roots of Morinda officinalis. Chinese Journal of Natural Medicines. 2010, 8(3): 192-195.
  158. Chen XP, Zhao HY, Zhong ZF, Xu ZT, Wang YT*. "Ox-LDL-LOX-1-ROS" Signaling Pathway Involvement in Foam Cell Formation. Chinese Journal of Arteriosclerosis. 2010, 18(7): 577-581.
  159. Zhang Y, Hu G, Lin HC, Hong SJ, Deng YH, Tang JY, Seto SW, Kwan YW, Waye MMY, Wang YT, Lee SMY. Radix Astragali Extract Promotes Angiogenesis involving Vascular Endothelial Growth Factor Receptor-related Phosphatidylinositol 3-Kinase/Akt-dependent Pathway in Human Endothelial Cells. Phytotherapy Research. 2009, 23(9): 1205-1213. (IF=1.746)
  160. Yu H, Li WM, Cheung MC, Zuo Z, Carlier PR, Gu ZM, Chan K, Huang M, Wang YT*, Han YF. Development and validation of an HPLC-DAD method for bis(12)-hupyridone and its application to a pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 2009, 49(2): 410-414. (IF=2.453)
  161. Xi J, Chang Q, Chan CK, Meng ZY, Wang GN, Sun JB, Wang YT, Tong HHY, Zheng Y. Formulation Development and Bioavailability Evaluation of a Self-Nanoemulsified Drug Delivery System of Oleanolic Acid. AAPS PharmSciTech. 2009, 10(1): 172-182. (IF=1.190)
  162. Wan JB, Lee SMY, Wang JD, Wang N, He CW, Wang YT*, Kang JX. Panax notoginseng Reduces Atherosclerotic Lesions in ApoE-Deficient Mice and Inhibits TNF-alpha-Induced Endothelial Adhesion Molecule Expression and Monocyte Adhesion. Journal of Agricultural and Food Chemistry. 2009, 57(15): 6692-6697. (IF=2.469)
  163. Sun YY, Xun KL, Wang YT, Chen XP. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anti-Cancer Drugs. 2009, 20(9): 757-769. (IF=2.230)
  164. Sun YY, Xun KL, Wang CG, Zhao HY, Bi HC, Chen XP, Wang YT. Adiponectin, an Unlocking Adipocytokine. Cardiovascular Therapeutics. 2009, 27(1): 59-75. (IF=2.741)
  165. Liu AL, Shu SH, Qin HL, Lee SMY, Wang YT, Du GH. In vitro Anti-Influenza Viral Activities of Constituents from Caesalpinia sappan. Planta Medica. 2009, 75(4): 337-339. (IF=2.037)
  166. Jiang Y, Li SP, Wang YT, Chen XJ, Tu PF. Differentiation of Herba Cistanches by fingerprint with high-performance liquid chromatography-diode array detection-mass spectrometry. Journal of Chromatography A. 2009, 1216(11): 2156-2162. (IF=4.101)
  167. Hong SJ, Wan JB, Zhang Y, Hu G, Lin HC, Seto SW, Kwan YW, Lin ZX, Wang YT, Lee SMY. Angiogenic Effect of Saponin Extract from Panax notoginseng on HUVECs In Vitro and Zebrafish In Vivo. Phytotherapy Research. 2009, 23(5): 677-686. (IF=1.746)
  168. Gao JL, Shi JM, Lee SMY, Zhang QW, Wang YT*. Angiogenic Pathway Inhibition of Corydalis yanhusuo and Berberine in Human Umbilical Vein Endothelial Cells. Oncology Research. 2009, 17(11-12): 519-526. (IF=1.478)
  169. Gao JL, He TC, Li YB, Wang YT*. A traditional Chinese medicine formulation consisting of Rhizoma Corydalis and Rhizoma Curcumae exerts synergistic anti-tumor activity. Oncology Reports. 2009, 22(5): 1077-1083. (IF=1.588)
  170. Chen XP, Xun KL, Chen LD, Wang YT. TNF-α, a potent lipid metabolism regulator. Cell Biochemistry and Function. 2009, 27(7): 407-416. (IF=1.515)
  171. Chen XJ, Zhao J, Meng Q, Li SP, Wang YT*. Simultaneous determination of five flavonoids in licorice using pressurized liquid extraction and capillary electrochromatography coupled with peak suppression diode array detection. Journal of Chromatography A. 2009, 1216(43): 7329-7335. (IF=4.101)
  172. Chen XJ, Tu PF, Jiang Y, Wang YT, Li SP. Effect of stability of internal standard on quantification of 15 flavonoids in Epimedium using CZE. Journal of Separation Science. 2009, 32(2): 275-281. (IF=2.551)
  173. Li GH, Zhang QW, Hang WH, Wang YT. Isoflavone C-glycosides from Pueraria lobata. Asian Chemistry Letters. 2009, 13(1&2): 35-40.
  174. Zhang L, Yu H, Li WM, Cheung MC, Pang YP, Gu ZM, Chan K, Wang YT, Zuo Z, Han YF. Preclinical characterization of intestinal absorption and metabolism of promising anti-Alzheimer's dimer bis(7)-tacrine. International Journal of Pharmaceutics. 2008, 357(1-2): 85-94. (IF=3.061)
  175. Yu H, Li WM, Kan KKW, Ho JMK, Carlier PR, Pang YP, Gu ZM, Zhong Z, Chan K, Wang YT*, Han YF. The physicochemical properties and the in vivo AChE inhibition of two potential anti-Alzheimer agents, bis(12)-hupyridone and bis(7)-tacrine. Journal of Pharmaceutical and Biomedical Analysis. 2008, 46(1): 75-81. (IF=2.629)
  176. Xiao Y, Yang FQ, Li SP, Hu G, Lee SMY, Wang YT. Essential oil of Curcuma wenyujin induces apoptosis in human hepatoma cells. World Journal of Gastroenterology. 2008, 14(27): 4309-4318. (IF=2.081)
  177. Wang J, Huang ZG, Cao H, Wang YT, Hui P, Hoo C, Li SP. Screening of anti-platelet aggregation agents from Panax notoginseng using human platelet extraction and HPLC-DAD-ESI-MS/MS. Journal of Separation Science. 2008, 31(6-7): 1173-1180. (IF=2.746)
  178. Wan JB, Zhang QW, Ye WC, Wang YT*. Quantification and separation of protopanaxatriol and protopanaxadiol type saponins from Panax notoginseng with macroporous resins. Separation and Purification Technology. 2008, 60(2): 198-205. (IF=2.503)
  179. Sa F, Gao JL, Fung KP, Zheng Y, Lee SMY, Wang YT. Anti-proliferative and pro-apoptotic effect of Smilax glabra Roxb. extract on hepatoma cell lines. Chemico-Biological Interactions. 2008, 171(1): 1-14. (IF=3.077)
  180. Luo XJ, Wang CZ, Chen J, Song WX, Luo JY, Tang N, He BC, Kang Q, Wang YT, Du W, He TC, Yuan CS. Characterization of gene expression regulated by American ginseng and ginsenoside Rg3 in human colorectal cancer cells. International Journal of Oncology. 2008, 32(5): 975-983. (IF=2.234)
  181. Liu AL, Wang HD, Lee SMY, Wang YT, Du GH. Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities. Bioorganic & Medicinal Chemistry. 2008, 16(15): 7141-7147. (IF=3.075)
  182. Liu AL, Liu B, Qin HL, Lee SMY, Wang YT, Du GH. Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa. Planta Medica. 2008, 74(8): 847-851. (IF=1.960)
  183. Li Z, Hu Y, Ming LW, Chun CM, Ping PY, Ge L, Wang YT, Zhong Z, Fan HY. Selective and sensitive determination of bis(7)-tacrine, a high erythrocyte binding acetylcholinesterase inhibitor, in rat plasma by high-performance liquid chromatography-tandem mass spectrometry. Biomedical Chromatography. 2008, 22(4): 414-420. (IF=1.592)
  184. Li P, Xu G, Li SP, Wang YT, Fan TP, Zhao QS, Zhang QW. Optimizing ultra performance liquid chromatographic analysis of 10 diterpenoid compounds in Salvia miltiorrhiza using central composite design. Journal of Agricultural and Food Chemistry. 2008, 56(4): 1164-1171. (IF=2.562)
  185. Lam HW, Lin HC, Lao SC, Gao JL, Hong SJ, Leong CW, Yue PYK, Kwan YW, Leung AYH, Wang YT*, Lee SMY. The angiogenic effects of Angelica sinensis extract on HUVEC in vitro and zebrafish in vivo. Journal of Cellular Biochemistry. 2008, 103(1): 195-211. (IF=3.540)
  186. Hu YJ, Bian Y, Wang YT*. Opening the Black Box of Pharmaceutical Patent Value: An Empirical Analysis. Drug Information Journal. 2008, 42(6): 561-568. (IF=0.504)
  187. Gao JL, Shi JM, He K, Zhang QW, Li SP, Lee SMY, Wang YT*. Yanhusuo extract inhibits metastasis of breast cancer cells by modulating mitogen-activated protein kinase signaling pathways. Oncology Reports. 2008, 20(4): 819-824. (IF=1.524)
  188. Chen XJ, Ji H, Zhang QW, Tu PF, Wang YT, Guo BL, Li SP. A rapid method for simultaneous determination of 15 flavonoids in Epimedium using pressurized liquid extraction and ultra-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 2008, 46(2): 226-235. (IF=2.629)
  189. Chen XJ, Ji H, Wang YT, Li SP. Simultaneous determination of seven flavonoids in Epimedium using pressurized liquid extraction and capillary electrochromatography. Journal of Separation Science. 2008, 31(5): 881-887. (IF=2.746)
  190. Yu H, Ho JMK, Kan KKW, Cheng BWH, Li WM, Zhang L, Lin G, Pang YP, Gu ZM, Chan K, Wang YT*, Han YF. Development of a high performance liquid chromatography-tandem mass method for determination of bis(7)-tacrine, a promising anti-Alzheimer's dimer, in rat blood. Journal of Pharmaceutical and Biomedical Analysis. 2007, 44(5): 1133-1138. (IF=2.761)
  191. Yang FQ, Li SP, Zhao J, Lao SC, Wang YT. Optimization of GC-MS conditions based on resolution and stability of analytes for simultaneous determination of nine sesquiterpenoids in three species of Curcuma rhizomes. Journal of Pharmaceutical and Biomedical Analysis. 2007, 43(1): 73-82. (IF=2.761)
  192. Yang FQ, Li SP, Li P, Wang YT. Optimization of CEC for simultaneous determination of eleven nucleosides and nucleobases in Cordyceps using central composite design. Electrophoresis. 2007, 28(11): 1681-1688. (IF=3.609)
  193. Xiao Y, Yang FQ, Li SP, Gao JL, Hu G, Lao SC, Conceicao EL, Fung KP, Wang YT*, Lee SMY. Furanodiene induces G(2)/M cell cycle arrest and apoptosis through MAPK signaling and mitochondria-caspase pathway in human hepatocellular carcinoma cells. Cancer Biology & Therapy. 2007, 6(7): 1044-1050. (IF=2.873)
  194. Wan JB, Li SP, Chen JM, Wang YT*. Chemical characteristics of three medicinal plants of the Panax genus determined by HPLC-ELSD. Journal of Separation Science. 2007, 30(6): 825-832. (IF=2.632)
  195. Qin NY, Yang FQ, Wang YT, Li SP. Quantitative determination of eight components in rhizome (Jianghuang) and tuberous root (Yujin) of Curcuma longa using pressurized liquid extraction and gas chromatography-mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 2007, 43(2): 486-492. (IF=2.761)
  196. Liu AL, Guang HM, Zhu LY, Du GH, Lee SMY, Wang YT. 3D-QSAR analysis of a new type of acetylcholinesterase inhibitors. Science in China Series C-Life Sciences. 2007, 50(6): 726-730. (IF=0.635)
  197. Li P, Li SP, Yang FQ, Wang YT*. Simultaneous determination of four tanshinones in salvia miltiorrhiza by pressurized liquid extraction and capillary electrochromatography. Journal of Separation Science. 2007, 30(6): 900-905. (IF=2.632)
  198. Leong CW, Wong CH, Lao SC, Leong EC, Lao LF, Law PTW, Fung KP, Tsang KS, Waye MMY, Tsui SKW, Wang YT*, Lee SMY. Effect of resveratrol on proliferation and differentiation of embryonic cardiomyoblasts. Biochemical and Biophysical Research Communications. 2007, 360(1): 173-180. (IF=2.749)
  199. Jiang Y, Li P, Li SP, Wang YT, Tu P. Optimization of pressurized liquid extraction of five major flavanoids from Lysimachia clethroide. Journal of Pharmaceutical and Biomedical Analysis. 2007, 43(1): 341-345. (IF=2.761)
  200. Gao JL, Leung KSY, Wang YT, Lai CM, Li SP, Hu LE, Lu GH, Jiang ZH, Yu ZL. Qualitative and quantitative analyses of nucleosides and nucleobases in Ganoderma spp. by HPLC-DAD-MS. Journal of Pharmaceutical and Biomedical Analysis. 2007, 44(3): 807-811. (IF=2.761)
  201. Chen XJ, Guo BL, Li SP, Zhang QW, Tu PF, Wang YT*. Simultaneous determination of 15 flavonoids in Epimedium using pressurized liquid extraction and high-performance liquid chromatography. Journal of Chromatography A. 2007, 1163(1-2): 96-104. (IF=3.641)
  202. Hu YJ, Ung COL, Bian Y, Wang YT*. Marketing StrategyThe Chinese pharmaceutical market: Dynamics and a proposed investment strategy. Journal of Medical Marketing. 2007, 7(1): 18-24.
  203. Hu YJ, Geng F, Bian Y, Wang YT*. The Chinese pharmaceutical market: Perspectives of the health consumer. Journal of Medical Marketing. 2007, 7(4): 295-300.
  204. Yu Y, Zhang QW, Wang YT, Li SP. A rapid HPLC method for determination of coniferyl ferulate in Angelica sinensis and Ligusticum chuanxiong. Journal of Chinese Pharmaceutical Sciences. 2007, 16(3): 197-201.
  205. Wang J, Wang YT, Li SP. Simultaneous determination of five nucleosides and nucleobases in Panax notoginseng using high-performance liquid chromatography. Journal of Chinese Pharmaceutical Sciences. 2007, 16(2): 79-83.
  206. Liu AL, Lee SMY, Wang YT, Du GH. Elsholtzia: review of traditional uses,chemistry and pharmacology. Journal of Chinese Pharmaceutical Sciences. 2007, 16(2): 73-78.
  207. Zhao J, Zhang XQ, Li SP, Yang FQ, Wang YT, Ye WC. Quality evaluation of Ganoderma through simultaneous determination of nine triterpenes and sterols using pressurized liquid extraction and high performance liquid chromatography. Journal of Separation Science. 2006, 29(17): 2609-2615. (IF=2.535)
  208. Zhao J, Li SP, Yang FQ, Li P, Wang YT. Simultaneous determination of saponins and fatty acids in Ziziphus jujuba (Suanzaoren) by high performance liquid chromatography-evaporative light scattering detection and pressurized liquid extraction. Journal of Chromatography A. 2006, 1108(2): 188-194. (IF=3.554)
  209. Yu L, Zhao J, Li SP, Fan H, Hong M, Wang YT, Zhu Q. Quality evaluation of Cordyceps through simultaneous determination of eleven nucleosides and bases by RP-HPLC. Journal of Separation Science. 2006, 29(7): 953-958. (IF=2.535)
  210. Yang FQ, Wang YT, Li SP. Simultaneous determination of 11 characteristic components in three species of Curcuma rhizomes using pressurized liquid extraction and high-performance liquid chromatography. Journal of Chromatography A. 2006, 1134(1-2): 226-231. (IF=3.554)
  211. Wan JB, Yang FQ, Li SP, Wang YT, Cui XM. Chemical characteristics for different parts of Panax notoginseng using pressurized liquid extraction and HPLC-ELSD. Journal of Pharmaceutical and Biomedical Analysis. 2006, 41(5): 1596-1601. (IF=2.032)
  212. Wan JB, Li P, Li SP, Wang YT, Dong TTX, Tsim KWK. Simultaneous determination of 11 saponins in Panax notoginseng using HPLC-ELSD and pressurized liquid extraction. Journal of Separation Science. 2006, 29(14): 2190-2196. (IF=2.535)
  213. Wan JB, Lai CM, Li SP, Lee MY, Kong LY, Wang YT*. Simultaneous determination of nine saponins from Panax notoginseng using HPLC and pressurized liquid extraction. Journal of Pharmaceutical and Biomedical Analysis. 2006, 41(1): 274-279. (IF=2.032)
  214. Liu JJ, Li SP, Wang YT. Optimization for quantitative determination of four flavonoids in Epimedium by capillary zone electrophoresis coupled with diode array detection using central composite design. Journal of Chromatography A. 2006, 1103(2): 344-349. (IF=3.554)
  215. Li SP, Zhang GH, Zeng Q, Huang ZG, Wang YT, Dong TTX, Tsim KWK. Hypoglycemic activity of polysaccharide, with antioxidation, isolated from cultured Cordyceps mycelia. Phytomedicine. 2006, 13(6): 428-433. (IF=1.403)
  216. Li P, Li SP, Wang YT. Optimization of CZE for analysis of phytochemical bioactive compounds. Electrophoresis. 2006, 27(23): 4808-4819. (IF=4.101)
  217. Li P, Li SP, Lao SC, Fu CM, Kan KKW, Wang YT*. Optimization of pressurized liquid extraction for Z-ligustilide, Z-butylidenephthalide and ferulic acid in Angelica sinensis. Journal of Pharmaceutical and Biomedical Analysis. 2006, 40(5): 1073-1079. (IF=2.032)
  218. Lai CM, Li SP, Yu H, Wan JB, Kan KW, Wang YT*. A rapid HPLC-ESI-MS/MS for qualitative and quantitative analysis of saponins in "XUESETONG" injection. Journal of Pharmaceutical and Biomedical Analysis. 2006, 40(3): 669-678. (IF=2.032)
  219. Jiang Y, Li SP, Chang HT, Wang YT, Tu PF. Pressurized liquid extraction followed by high-performance liquid chromatography for determination of seven active compounds in Cortex Dictamni. Journal of Chromatography A. 2006, 1108(2): 268-272. (IF=3.554)
  220. Hu LF, Li SP, Cao H, Liu JJ, Gao JL, Yang FQ, Wang YT*. GC-MS fingerprint of Pogostemon cablin in China. Journal of Pharmaceutical and Biomedical Analysis. 2006, 42(2): 200-206. (IF=2.032)
  221. Fan H, Li SP, Xiang JJ, Lai CM, Yang FQ, Gao JL, Wang YT. Qualitative and quantitative determination of nucleosides, bases and their analogues in natural and cultured Cordyceps by pressurized liquid extraction and high performance liquid chromatography-electrospray ionization tandem mass spectrometry (HPLC-ESI-MS/MS). Analytica Chimica Acta. 2006, 567(2): 218-228. (IF=2.894)
  222. Yang FQ, Li SP, Chen Y, Lao SC, Wang YT, Dong TTX, Tsim KWK. Identification and quantitation of eleven sesquiterpenes in three species of Curcuma rhizomes by pressurized liquid extraction and gas chromatography-mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 2005, 39(3-4): 552-558. (IF=1.889)
  223. Wan JB, Xu C, Li SP, Kong LY, Wang YT*. Studies on the pressurized solvent extraction of isoflavonoids from Pueraria lobata. Chinese Journal of Analytical Chemistry. 2005, 33(10): 1435-1438. (IF=0.397)
  224. Liu AL, Wang YT, Du GH. Neuraminidase as a target for drugs for the treatment of influenza. Drugs of the Future. 2005, 30(8): 799-806. (IF=0.547)
  225. Gong YX, Li SP, Wang YT, Li P, Yang FQ. Simultaneous determination of anthraquinones in rhubarb by pressurized liquid extraction and capillary zone electrophoresis. Electrophoresis. 2005, 26(9): 1778-1782. (IF=3.850)
  226. Yu Z, Jiang B, Wang YT, Shi LW. Current Status and Development Strategies of TCMM Exportation in China. Journal of Chinese Pharmaceutical Sciences. 2005, 14(1): 65-68.
  227. Li XZ, Jiang B, Wang YT, Shi LW. Current Status and Development Strategies of Chinese Cosmetic Industry. Journal of Chinese Pharmaceutical Sciences. 2005, 14(1): 72-74.
  228. Li SP, Li P, Lai CM, Gong YX, Kan KKW, Dong TTX, Tsim KWK, Wang YT. Simultaneous determination of ergosterol, nucleosides and their bases from natural and cultured Cordyceps by pressurised liquid extraction and high-performance liquid chromatography. Journal of Chromatography A. 2004, 1036(2): 239-243. (IF=3.359)
  229. Lao SC, Li SP, Kan KKW, Li P, Wan JB, Wang YT*, Dong TTX, Tsim KWK. Identification and quantification of 13 components in Angelica sinensis (Danggui) by gas chromatography-mass spectrometry coupled with pressurized liquid extraction. Analytica Chimica Acta. 2004, 526(2): 131-137. (IF=2.588)
  230. Gong YX, Li SP, Li P, Liu JJ, Wang YT. Simultaneous determination of six main nucleosides and bases in natural and cultured Cordyceps by capillary electrophoresis. Journal of Chromatography A. 2004, 1055(1-2): 215-221. (IF=3.359)

Chinese peer-reviewed journals

  1. 于小文, 張秀婷, 胡豪, 王一濤. 美歐中貝特類藥物技術分析及預測——基於授權專利分析. 情報雜誌. 2014, 33(2): 44-47.
  2. 倪靜雲, 蔡勇, 李志堅, 胡元佳, 王一濤. 我國大學技術轉移現狀及策略探析. 科技管理研究. 2014, (5): 189-193.
  3. 馬志橋, 楊檸, 胡豪, 王一濤, 阿爾帕提·沙迪克. 知識基礎轉移與傳統產業轉型:以新疆維吾爾醫藥產業為例. 科技進步與對策. 2014, 31(2): 144-148.
  4. 景王慧, 吳文進, 燕茹, 王一濤*. 歸肺經中藥桑白皮的化學、藥理與藥代動力學研究進展. 世界中醫藥. 2014, 9(1): 109-112,116.
  5. 陳宇寧, 于小文, 胡豪, 王一濤. 基於專利分析的美歐中貝特類藥物技術類型及機構分佈對比分析. 中國新藥雜誌. 2014, 23(6): 631-634,639.
  6. 張君隆, 于小文, 胡豪, 王一濤. 美國紐約、中國澳門和中國珠海社區藥房基礎服務的對比分析. 藥學服務與研究. 2013, 13(2): 143-146.
  7. 于元元, 馮柳, 劉京京, 邱嵐, 胡元佳, 王一濤*. 抗腫瘤藥物全球市場分析. 中國藥學雜誌. 2013, 48(2): 155-158.
  8. 申東豔, 陳美婉, 王勝鵬, 李鵬, 王一濤*. 抗腫瘤中藥新型藥物傳遞系統的研究(二)——活血化瘀類中藥. 世界科學技術-中醫藥現代化. 2013, 15(1): 34-39.
  9. 倪靜雲, 蔡勇, 徐嘉辰, 胡元佳, 王一濤. 專利許可與中藥國際化發展的策略探討. 中草藥. 2013, 44(21): 3080-3083.
  10. 馬志橋, 章懋妤, 胡豪, 王一濤. 新疆維吾爾藥成藥研究進展——基於專利申請與學術文獻分析. 中國民族民間醫藥. 2013, (15): 4-7.
  11. 馬志橋, 章懋妤, 陳美婉, 胡豪, 王一濤. 新疆維吾爾藥材研究概況:基於專利申請與學術發表. 中藥材. 2013, 36(12): 2071-2074.
  12. 馬志橋, 於元元, 胡豪, 王一濤. 基於結構視角下的中國製藥產業集群中的政府行為. 科技管理研究. 2013, (14): 40-44.
  13. 劉京京, 於元元, 邱嵐, 王一濤. 營養信息傳播者在新浪微博上的影響力及關係網絡實證研究. 知識管理論壇. 2013, (6): 7-14.
  14. 劉京京, 於元元, 邱嵐, 王一濤*. 中藥材地理標誌註冊登記的現狀與分析. 中國藥房. 2013, 24(3): 193-195.
  15. 陳銳娥, 王勝鵬, 胡楊洋, 陳美婉, 王一濤*. 抗腫瘤中藥新型藥物傳遞系統的研究(三)——扶正固本類中藥. 世界科學技術-中醫藥現代化. 2013, 15(2): 201-206.
  16. 蔡勇, 胡豪, 倪靜雲, 王一濤. 中藥質量追溯體系發展現狀研究. 中國中藥雜誌. 2013, 38(22): 3829-3833.
  17. 張楠, 張露, 王一濤. 中國仿製藥品牌戰略研究. 科技管理研究. 2012, (23): 108-112.
  18. 張君隆, 葛帥, 胡豪, 王一濤*. 珠海、澳門和紐約社區藥房醫學服務的對比研究. 中國醫藥導報. 2012, 9(27): 129-131.
  19. 于小文, 符永鈺, 胡豪, 王一濤. 商業模式視角下的中成藥產品創新選擇. 中國醫藥技術經濟與管理. 2012, (4): 54-58.
  20. 徐文珊, 陸金健, 陳修平, 王一濤*. 基於內質網應激的抗腫瘤藥物研發. 中國藥理學通報. 2012, 28(12): 1659-1665.
  21. 徐文珊, 黃鳴清, 陳修平, 王一濤*. 天然產物來源的芳香化酶抑制劑研究進展. 時珍國醫國藥. 2012, 23(4): 1008-1011.
  22. 王一濤, 潘威, 劉京京, 陳美婉. 粵澳合作共建創新型中醫藥科技產業園. 中國科技產業. 2012, (9): 62-65.
  23. 王勝鵬, 申東豔, 李鵬, 陳美婉, 王一濤*. 抗腫瘤中藥新型藥物傳遞系統的研究(一)——清熱解毒類中藥. 世界科學技術(中醫藥現代化). 2012, 14(6): 2131-2135.
  24. 王勝鵬, 胡楊洋, 陳銳娥, 鐘章鋒, 陳美婉, 王一濤*. 中藥藥對的系統研究(Ⅱ)——藥效與藥動學研究. 世界科學技術(中醫藥現代化). 2012, 14(2): 1322-1328.
  25. 王勝鵬, 陳美婉, 王一濤*. 葛花化學成分和藥理活性研究進展. 中藥藥理與臨床. 2012, 28(2): 193-196.
  26. 王勝鵬, 陳美婉, 王一濤*. 中藥藥對的系統研究(Ⅰ)——理論與物質基礎研究. 世界科學技術(中醫藥現代化). 2012, 14(2): 1317-1321.
  27. 史洪昊, 胡豪, 王一濤. 競合視角下的中國醫藥企業間合作. 科技管理研究. 2012, (5): 116-118, 123.
  28. 史洪昊, 胡豪, 王一濤. 從商業模式探究中國單抗產品的發展路徑. 科技管理研究. 2012, (21): 111-114.
  29. 石韻臻, 胡豪, 王一濤. 自主研發還是外部獲取?——中國生物製藥商業模式的技術考量. 管理案例研究與評論. 2012, 5(3): 205-212.
  30. 潘威, 李玲, 胡元佳, 王一濤. 藥物研發與製藥企業績效——基於國際大型製藥公司藥物開發管道的定量分析. 科技進步與對策. 2012, 29(8): 91-94.
  31. 陸金健, 黃鳴清, 陳修平, 王一濤*. 表達蛋白質組學在抗腫瘤藥物研發中的應用. 中國新藥雜誌. 2012, 21(1): 43-47.
  32. 陸金健, 黃鳴清, 陳修平, 王一濤*. 二氫青蒿素抗腫瘤作用及其機制研究進展. 中國藥理學與毒理學雜誌. 2012, 26(3): 397-401.
  33. 李西文, 高歡歡, 王一濤, 宋經元, Robert H, 吳和珍, 胡志剛, 姚輝, 羅紅梅, 羅焜, 潘宏林, 陳士林. 荷花玉蘭葉綠體全基因組高通量測序及結構解析. 中國科學:生命科學. 2012, 42(12): 947-956.
  34. 賴雲鋒, 陸金健, 陳修平, 胡豪, 王一濤*. 基於市場狀況的抗腫瘤中藥注射劑分析. 世界科學技術(中醫藥現代化). 2012, 14(5): 1958-1962.
  35. 黃鳴清, 許文, 褚克丹, 陸金健, 陳修平, 王一濤. 基於GLUT4轉位的中藥及活性成分改善胰島素抵抗研究進展. 中國實驗方劑學雜誌. 2012, 18(16): 343-346.
  36. 胡楊洋, 王勝鵬, 陳銳娥, 陳美婉, 王一濤*. 趕黃草的藥學研究和應用. 中藥藥理與臨床. 2012, 28(3): 136-140.
  37. 胡楊洋, 陳銳娥, 王勝鵬, 陳美婉, 王一濤*. 中藥藥對的系統研究(Ⅵ)——黃芪當歸藥對研究. 世界科學技術(中醫藥現代化). 2012, 14(2): 1349-1356.
  38. 郭楊, 劉超, 胡元佳, 王一濤. 外國製藥企業在我國專利佈局分析. 中國醫藥工業雜誌. 2012, 43(12): A124-A127.
  39. 龔健, 王勝鵬, 陳美婉, 王一濤*. 中藥藥對的系統研究(Ⅲ)——藥劑學理論和新製劑開發. 世界科學技術(中醫藥現代化). 2012, 14(2): 1329-1333.
  40. 高建莉, 陳兆飛, 石俊敏, 王一濤, 呂圭源. 延胡索中5種生物鹼的含量測定及穩定性研究. 中國藥房. 2012, 23(15): 1386-1388.
  41. 馮柳, 曹晨, 於元元, 胡元佳, 王一濤*. 1991-2010年26個撤市藥品分析. 中國藥房. 2012, 23(33): 3158-3159.
  42. 陳修平, 陸金健, 郭佳傑, 鮑嬌琳, 徐文珊, 丁倩, 王一濤. 基於天然產物的藥物研發對創新中藥研究的啟示——TTD收錄天然藥物分析. 藥學學報. 2012, 47(11): 1423-1427.
  43. 陳銳娥, 申東豔, 李鵬, 王勝鵬, 胡楊洋, 陳美婉, 王一濤*. 中藥藥對的系統研究(Ⅴ)——丹參三七藥對研究. 世界科學技術(中醫藥現代化). 2012, 14(2): 1342-1348.
  44. 陳銳娥, 胡楊洋, 王勝鵬, 陳美婉, 王一濤*. 中藥藥對的系統研究(Ⅳ)——黃連吳茱萸藥對研究. 世界科學技術(中醫藥現代化). 2012, 14(2): 1334-1341.
  45. 陳美婉, 鐘章鋒, 王勝鵬, 王一濤*. β-欖香烯抗癌活性及其新型給藥系統的研究進展. 中國新藥雜誌. 2012, 21(12): 1358-1361, 1388.
  46. 陳美婉, 陳文榮, 陳桐楷, 陳銳娥, 王一濤*. 熱熔擠出技術製備固體分散體的應用研究. 藥學學報. 2012, 47(2): 163-167.
  47. 陳聰, 於元元, 胡元佳, 王一濤*. 基於區位商分析我國中藥產業佈局. 中國中藥雜誌. 2012, 37(5): 549-552.
  48. 陳聰, 胡元佳, 王一濤*. 人口老齡化對我國衛生費用的影響. 中國衛生統計. 2012, 29(3): 430-432.
  49. 晁芳, 邱嵐, 胡元佳, 王一濤*. ERP實施對製藥類上市企業績效影響的實證研究. 中國藥房. 2012, 23(5): 387-390.
  50. 曹晨, 劉京京, 胡元佳, 王一濤. 基於技術、商業、法律的中藥商業價值分析. 南京中醫藥大學學報(社會科學版). 2012, 13(2): 111-115.
  51. 鮑嬌琳, 陸金健, 陳修平, 王一濤*. 苦參堿與氧化苦參堿抗腫瘤作用及其機制的研究進展. 中藥新藥與臨床藥理. 2012, 23(3): 369-373.
  52. 趙揚, 胡豪, 王一濤*. 基於發展中國家相關案例探索我國製藥企業產業升級的突破路徑. 中國藥房. 2011, 22(33): 3076-3078.
  53. 張時開, 胡元佳, 尹恒, 王一濤. 藥物靶點與經濟價值——基於2000~2009年美國上市新藥的實證研究. 科技管理研究. 2011, (23): 172-175.
  54. 張時開, 胡元佳, 劉京京, 王一濤. 中藥製藥企業合作創新模式研究. 科技管理研究. 2011, (10): 88-91.
  55. 余文心, 史錄文, 王一濤. 我國醫藥儲備制度存在的問題淺析及政策建議. 中國藥房. 2011, 22(9): 780-782.
  56. 余文心, 胡豪, 史錄文, 王一濤. 研發導向型製藥企業外部資源整合行為探究. 科技進步與對策. 2011, 28(4): 85-89.
  57. 于元元, 劉京京, 卞鷹, 王一濤. 中國醫院床位資源分佈公平性研究. 中國衛生資源. 2011, 14(6): 394-396.
  58. 熊秀莉, 鄭穎, 王一濤. 輔料聯用固體分散技術在丹參提取物多組分釋放中的研究. 中草藥. 2011, 42(1): 50-55.
  59. 孫靜, 殷志琦, 張慶文, 葉文才, 王一濤, 趙守訓. 赤靈芝乙酸乙酯萃取部位的化學成分. 中國藥科大學學報. 2011, 42(3): 220-222.
  60. 蘇偉萍, 宋瑞霖, 王一濤, 史錄文. 發展我國仿製藥大品種的對策. 中國新藥雜誌. 2011, 20(3): 200-203.
  61. 宋燕, 胡元佳, 卞鷹, 王一濤. 藥品技術價值與經濟價值的相關性分析. 中國藥房. 2011, 22(13): 1153-1155.
  62. 邱嵐, 於元元, 劉京京, 王一濤. 近年來港幣在澳門流通情況的實證分析. 特區經濟. 2011, (10): 13-15.
  63. 邱嵐, 胡元佳, 王一濤. 營利性醫療機構的發展現狀及投資前景. 經濟導刊. 2011, (6): 55-57.
  64. 邱嵐, 胡元佳, 王一濤. 針對藥源性損害的責任保險探析. 保險研究. 2011, (6): 82-87.
  65. 潘威, 胡元佳, 王一濤*. 針灸技術創新的國際化——基於美國針灸專利的定量分析. 中國針灸. 2011, 31(8): 749-752.
  66. 李玲, 潘威, 胡元佳, 王一濤*. 中國醫藥行業發展藥妝市場的道路探索. 企業經濟. 2011, (8): 83-85.
  67. 何佩雯, 杜鋼, 趙海譽, 王一濤*. 微波消解-石墨爐原子吸收光譜法測定9種中藥材中微量元素含量. 中華中醫藥雜誌. 2011, 26(2): 271-274.
  68. 傅舒, 陸金健, 陳修平, 王一濤*. 莪術中萜類成分抗腫瘤作用的研究進展. 華西藥學雜誌. 2011, 26(6): 604-606.
  69. 陳修平, 鐘章鋒, 徐曾濤, 燕茹, 李澎濤, 王一濤*. 基於藥效物質基礎的中藥藥物代謝動力學. 世界科學技術(中醫藥現代化). 2011, 13(1): 137-142.
  70. 陳修平, 裴麗霞, 王一濤. 創新中藥研究與開發模式探討. 中草藥. 2011, 42(7): 1255-1260.
  71. 陳修平, 胡元佳, 王一濤*. 中藥方劑創新研究的啟示與思考——從《科學轉化醫學》首次發表中醫方劑研究論文談起. 世界科學技術(中醫藥現代化). 2011, 13(4): 704-706.
  72. 陳美婉, 陳文榮, 李書淵, 王勝鵬, 鐘章鋒, 王一濤*. 廣東狼毒的化學成分及藥理作用的研究進展. 中藥藥理與臨床. 2011, 27(3): 128-131.
  73. 陳美婉, 陳銳娥, 李穎博, 譚雯, 王一濤*. 冬淩草甲素納米製劑的研究和應用. 中國實驗方劑學雜誌. 2011, 17(16): 284-287.
  74. 陳聰, 胡元佳, 王一濤*. 中國醫療衛生收入的貢獻因素分析. 中國衛生事業管理. 2011, (5): 326-328.
  75. 晁芳, 胡元佳, 王一濤*. 影響我國製藥企業成功實施ERP的因素分析及策略. 中國藥房. 2011, 22(41): 3841-3843.
  76. 鐘章鋒, 陳修平, 吳鐵, 王一濤*. 莪術醇的研究進展. 中國藥房. 2010, 21(31): 2959-2961.
  77. 姚驥如, 卞鷹, 王一濤, 謝丹紅. 南方某大型三甲醫院2216例住院死亡病例分析. 中國衛生統計. 2010, 27(6): 630-631.
  78. 姚驥如, 卞鷹, 王一濤, 孫瑩, 羅順葵. 新醫改模式下我國醫院藥學發展的思考與探索. 中國醫院管理. 2010, 30(3): 52-53.
  79. 吳霞, 畢贏, 王一濤*. 前胡化學成分及藥理作用的研究進展. 食品與藥品. 2010, 12(11): 442-445.
  80. 蘇偉萍, 胡豪, 史錄文, 王一濤. 製藥行業me too藥的自主開發策略. 中國新藥雜誌. 2010, 19(11): 926-929.
  81. 彭學韜, 胡豪, 王一濤. 品牌管理策略:王老吉品牌成功的原因. 企業活力. 2010, (3): 28-32.
  82. 彭學韜, 胡豪, 王一濤. 中藥企業創新路徑選擇——以香港維特健靈和培力為借鑒. 特區經濟. 2010, (5): 287-289.
  83. 彭學韜, 胡豪, 王一濤. 中藥企業創新系統構建:以香港培力為案例. 企業活力. 2010, (8): 23-27.
  84. 潘威, 胡元佳, 王一濤*. 跨國醫藥公司在華專利申請格局研判. 科技管理研究. 2010, (22): 190-192, 195.
  85. 李響, 萬建波, 李銘源, 王一濤. 葛根異黃酮類化合物抗動脈粥樣硬化藥理研究進展. 中國新藥雜誌. 2010, 19(8): 662-665.
  86. 李玲, 張怡然, 胡元佳, 王一濤*. 基於疾病、藥物和市場因素的全球暢銷藥物分析. 中國醫藥工業雜誌. 2010, 41(9): 709-713.
  87. 李國輝, 張慶文, 王一濤. 葛根的化學成分研究. 中國中藥雜誌. 2010, 35(23): 3156-3160.
  88. 黃振華, 胡豪, 王一濤. 跨國藥企在華技術溢出的途徑分析. 生產力研究. 2010, (8): 125-126, 144.
  89. 胡豪, 範妙璿, 王一濤. 中國CRO企業產業價值鏈定位與製藥產業創新能力. 中國醫藥技術經濟與管理. 2010, (5): 64-67.
  90. 何秀瓊, 裴利霞, 王一濤, 鄭穎. 高效液相色譜法研究大鼠灌胃黃芩素的藥動學. 中國醫院藥學雜誌. 2010, 30(22): 1901-1905.
  91. 何佩雯, 趙海譽, 杜鋼, 王一濤*. 氣相色譜技術在中藥農藥殘留檢測中的應用. 中國實驗方劑學雜誌. 2010, 16(2): 126-134.
  92. 何佩雯, 杜鋼, 趙海譽, 王波, 王一濤*. 微波消解-原子吸收光譜法測定9種中藥材中重金屬含量. 藥物分析雜誌. 2010, 30(9): 1707-1712.
  93. 耿向楠, 韓晟, 胡豪, 史錄文, 王一濤. 藥物經濟學循證方法淺析. 中國藥物經濟學. 2010, (4): 40-45.
  94. 馮雪敏, 胡豪, 王一濤. 集團體制下的業務組合構建及其管控. 中國經貿導刊. 2010, (19): 62.
  95. 范妙璇, 胡豪, 趙海譽, 王一濤. 中國醫藥研發外包行業競爭優勢研究. 中國科技論壇. 2010, (5): 36-40, 46.
  96. 陳修平, 尋克麗, 王一濤*. 中藥複方藥效物質基礎的系統藥理學評價. 中草藥. 2010, 41(1): 1-5.
  97. 張燁, 鄭穎, 王一濤. 應用改進的質量評價方法考察複方丹參製劑. 中成藥. 2009, 31(12): 1855-1860.
  98. 張翔宇, 王一濤. 甘草資源困境分析與保護策略. 國土與自然資源研究. 2009, (3): 95-96.
  99. 張珵, 胡豪, 王一濤. 搜尋引擎作為醫藥傳媒的道德考量. 中國衛生事業管理. 2009, (7): 499-501.
  100. 余文心, 史錄文, 王一濤. 製藥企業藥品開發項目中研發與行銷的整合. 中國醫藥技術經濟與管理. 2009, 3(6): 55-60.
  101. 徐樹明, 楊明, 梁雪丹, 王一濤, 鄭穎. 苦參堿時控型結腸定位給藥微丸的製備和體外釋藥研究. 中國藥學雜誌. 2009, 44(22): 1713-1718.
  102. 謝元昊, 胡豪, 譚睿, 王一濤*. 基因工程技術與中藥藥效評價. 中國天然藥物. 2009, 7(6): 476-480.
  103. 湯瑞瑞, 卞鷹, 王一濤. 論我國中藥不良反應的現狀及其預防和監管. 時珍國醫國藥. 2009, 20(2): 492-494.
  104. 湯瑞瑞, 卞鷹, 王一濤. 《中藥品種保護條例》和專利對中藥保護的關係探討. 時珍國醫國藥. 2009, 20(5): 1291-1293.
  105. 彭學韜, 胡豪, 王一濤. 跨國製藥企業在華創新研發投入的研究. 中國藥業. 2009, 18(16): 13-14.
  106. 賀凱, 高建莉, 趙光樹, 王一濤*. 公共治理在基本藥物供應體系建立中的意義. 中國藥房. 2009, 20(14): 1041-1043.
  107. 范妙璇, 趙海譽, 王一濤. 中藥大黃現代藥理學研究與中西醫結合的應用. 中國醫藥指南. 2009, 7(8): 41-42, 20.
  108. 范妙璇, 胡豪, 趙海譽, 王一濤*. 提高由國醫藥科技國際競爭力途徑——中國醫藥行業研發聯盟現狀研究. 中國醫藥技術經濟與管理. 2009, 3(5): 38-45.
  109. 范妙璇, 卞鷹, 趙海譽, 王一濤*. 中日兩國關於提高老年人生活質量的政策比較. 醫學與哲學(人文社會醫學版). 2009, 30(7): 30-32.
  110. 杜禎, 鄭穎, 黎暢明, 王一濤, 唐海誼. 噴霧冷凍乾燥技術進展及其在藥劑學中的應用. 中國藥學雜誌. 2009, 44(10): 724-727.
  111. 党元野, 陳修平, 張慶文, 王一濤*. 辣椒堿的藥理作用研究進展. 中藥藥理與臨床. 2009, 25(4): 84-89.
  112. 周明眉, 楊奎, 王一濤, 寇芳. 大川芎方對偏頭痛模型大鼠行為學和硬腦膜炎症的影響. 中藥藥理與臨床. 2008, 24(4): 9-10.
  113. 周明眉, 楊奎, 王一濤. 從血液流變學和血流速度評價大川芎丸方中川芎天麻治療偏頭痛的協同作用. 中藥藥理與臨床. 2008, 24(3): 6-8.
  114. 趙一, 何曉強, 席佳, 任科, 龔濤, 王一濤, 鄭穎. 當歸揮發油中Z-槁本內酯的分離純化及其製劑的穩定性. 華西藥學雜誌. 2008, 23(5): 533-535.
  115. 張煥, 王一濤*, 嚴燦, 張慶文, 李紹平. 當歸與川芎藥理作用研究進展與比較. 時珍國醫國藥. 2008, 19(2): 293-295.
  116. 張珵, 胡豪, 王一濤. 醫藥傳媒的特徵、作用及其發展策略初探. 中國衛生事業管理. 2008, (7): 497-499.
  117. 于楠, 高建莉, 洪思佳, 李銘源, 王一濤. 左旋四氫巴馬丁抗動脈粥樣硬化作用的體外研究. 中藥藥理與臨床. 2008, 24(3): 27-29.
  118. 謝元昊, 王一濤, 譚睿. 生物醫藥領域的技術預見. 成都中醫藥大學學報. 2008, 30(4): 78-81.
  119. 奚瑋瑋, 李銘源, 王寧生, 宓穗卿, 王一濤*. 黑升麻治療婦女圍絕經期綜合征的臨床研究. 時珍國醫國藥. 2008, 19(10): 2555-2557.
  120. 王楠, 萬建波, 李銘源, 王一濤*. 三七治療動脈粥樣硬化的研究進展. 中草藥. 2008, 39(5): 787-790.
  121. 孫良堃, 張珵, 王一濤, 張忠元. 市場導向下的高等藥學人才培養模式探討. 成都中醫藥大學學報(教育科學版). 2008, 10(2): 1-3.
  122. 孫良堃, 胡豪, 王一濤. 互聯網對處方藥宣傳的平臺作用研究. 中國藥業. 2008, 17(16): 11-12.
  123. 石俊敏, 管佳, 張慶文, 李紹平, 葉文才, 王一濤*. 超高效液相色譜在藥物分析中的應用. 藥物分析雜誌. 2008, 28(9): 1583-1588.
  124. 秦祐鵬, 胡豪, 王一濤*. 中藥企業國際化策略案例比較. 中國醫藥工業雜誌. 2008, 39(11): 874-876.
  125. 梁慶優, 鄭穎, 唐海誼, 李紹平, 王一濤. HPLC法測定靜態加壓溶劑提取馬兜鈴屬植物中馬兜鈴酸. 中草藥. 2008, 39(3): 364-368.
  126. 黃洲萍, 王一濤*, 胡豪, 胡元佳, 孫良堃. 澳門中醫藥科技與產業發展策略研究. 世界科學技術-中醫藥現代化. 2008, 10(2): 112-115.
  127. 胡元佳, 卞鷹, 王一濤. 專利價值的理論探討. 科技管理研究. 2008, (5): 246-249.
  128. 鄧豔輝, 李銘源, 黃河清, 王一濤. 白藜蘆醇抗動脈粥樣硬化作用研究進展. 中山大學學報(醫學科學版). 2008, 29(S2): 163-165.
  129. 陳肖家, 李紹平, 王一濤, 屠鵬飛. HPLC、UPLC、CZE測定淫羊藿中黃酮類成分含量的比較研究. 中國藥學雜誌. 2008, 43(8): 624-628.
  130. 張燚, 胡光, 洪思佳, 劉倩青, 李銘源, 王一濤. 黃芪提取物對人臍靜脈內皮細胞的促血管新生作用. 中藥藥理與臨床. 2007, 23(2): 34-37.
  131. 余華, 李文明, 簡家榮, 陳金泉, 王一濤, 韓怡凡. 治療阿爾茨海默病藥的藥動學研究進展. 中國藥學雜誌. 2007, 42(15): 1121-1125.
  132. 修春, 李銘源, 宓穗卿, 王一濤*. 桃仁的主要化學成分及藥理研究進展. 中國藥房. 2007, 18(24): 1903-1904.
  133. 謝京晶, 於玥, 王一濤, 李紹平. HPLC法同時測定當歸藥材中6種成分的含量. 藥物分析雜誌. 2007, 27(9): 1314-1317.
  134. 王薇, 張慶文, 葉文才, 王一濤. 黃連中的異喹啉類生物鹼. 中國天然藥物. 2007, 5(5): 348-350.
  135. 倪靜雲, 卞鷹, 王一濤. 國內外CRO發展現狀的比較分析. 科技進步與對策. 2007, 24(4): 198-200.
  136. 劉艾林, 李銘源, 王一濤, 杜冠華. 丹參藥理學活性物質基礎研究現狀. 中國藥學雜誌. 2007, 42(9): 641-646.
  137. 劉艾林, 光紅梅, 朱莉亞, 杜冠華, 李銘源, 王一濤. 新型乙醯膽鹼酯酶抑制劑的三維定量構效關係研究. 中國科學(C輯:生命科學). 2007, 37(5): 503-507.
  138. 冷薇, 鄭穎, 王一濤. 莪術油吸收機制及其口服製劑開發. 中華醫藥雜誌. 2007, 7(3): 221-225.
  139. 冷薇, 鄭穎, 李紹平, 楊豐慶, 王一濤. 莪術油在Caco-2細胞模型中的吸收機制研究. 中國藥學雜誌. 2007, 42(16): 1228-1232.
  140. 金思岑, 胡元佳, 王一濤*. 中國與歐美製藥產業的比較分析——結構、行為與績效. 中國醫藥工業雜誌. 2007, 38(7): A79-A84.
  141. 金思岑, 胡元佳, 王一濤. 論醫院非價格競爭之利弊及建議. 中國藥房. 2007, 18(31): 2401-2402.
  142. 黃洲萍, 王一濤, 卞鷹. 孔子的“義利觀”與醫院的經營之道. 醫學與哲學(人文社會醫學版). 2007, 28(5): 40-42.
  143. 黃洲萍, 王一濤. 以港澳為平臺推進中藥國際化發展. 中國現代中藥. 2007, 9(7): 4-7.
  144. 黃洲萍, 王一濤. 廣東省藥品網上陽光採購之我見. 衛生經濟研究. 2007, (8): 27-28.
  145. 黃洲萍, 王一濤. 歐盟、中國製劑藥生產質量管制規範比較. 中國衛生事業管理. 2007, (8): 539-540.
  146. 胡元佳, 虞忠, 卞鷹, 王一濤*. 專利異議狀況與藥品經濟價值的相關性研究. 中國藥房. 2007, 18(19): 1449-1451.
  147. 胡元佳, 卞鷹, 王一濤. Lanjouw-Schankerman專利價值評估模型在製藥企業品種選擇中的應用. 中國醫藥工業雜誌. 2007, 38(2): A20-A22.
  148. 胡元佳, 卞鷹, 王一濤. 非市場基準的專利價值評估方法探討——以Harhoff等人的實證研究為例. 軟科學. 2007, 21(4): 17-20.
  149. 洪思佳, 王一濤, 李銘源. 石杉堿甲藥理與臨床研究進展. 中藥藥理與臨床. 2007, 23(1): 83-86.
  150. 洪思佳, 萬建波, 張慶文, 張燚, 胡光, 劉倩青, 李銘源, 王一濤. 三七總皂苷對人臍靜脈內皮細胞的促血管新生作用. 中藥藥理與臨床. 2007, 23(2): 28-30.
  151. 陳肖家, 張慶文, 季暉, 王一濤, 屠鵬飛, 李紹平. 紫外分光光度法和高效液相色譜法測定淫羊藿總黃酮含量的比較研究. 藥物分析雜誌. 2007, 27(5): 625-630.
  152. 趙靜, 卞鷹, 李紹平, 王一濤*. 中藥化學對照品市場化的研究. 華西藥學雜誌. 2006, 21(3): 316-318.
  153. 虞忠, 卞鷹, 胡元佳, 王一濤. 我國中藥占國際市場份額的測算及相關概念辨析. 中國藥房. 2006, 17(5): 328-330.
  154. 楊馨湄, 卞鷹, 王一濤. 淺析連鎖藥店差異化發展. 中國藥房. 2006, 17(11): 878-879.
  155. 肖妤, 李紹平, 王一濤. 紅景天苷藥理研究進展. 實用醫院臨床雜誌. 2006, 3(3): 98-99.
  156. 王談淩, 車明鳳, 王一濤. 國際傳統醫藥知識權益維權案例與思考. 中國新藥雜誌. 2006, 15(19): 1609-1612.
  157. 萬建波, 李紹平, 王一濤*. 中藥三七高效液相色譜特徵研究. 藥學學報. 2006, 41(11): 1090-1093.
  158. 孫靈犀, 卞鷹, 王一濤. 淺析我國違法藥品廣告. 四川省衛生管理幹部學院學報. 2006, 25(2): 144, 150.
  159. 孫靈犀, 卞鷹, 王一濤. 我國藥品廣告監管體系的完善和發展. 衛生軟科學. 2006, 20(5): 448-450.
  160. 沙飛, 禹志領, 王一濤. 土茯苓品質與藥理研究進展. 中藥材. 2006, 29(5): 516-519.
    • 沙飛, 李紹平, 王一濤. 中藥急救劑型的研究進展. 澳門醫學雜誌. 2006, 6(2): 127-130.
    • 邱嵐, 卞鷹, 王一濤. 我國醫藥行業上市公司並購績效的實證研究. 中國藥房. 2006, 17(19): 1448-1451.
    • 倪靜雲, 卞鷹, 王一濤. 中藥產業應通過合作創新提高競爭力. 中國藥業. 2006, 15(1): 9-10.
    • 倪靜雲, 卞鷹, 王一濤. 探討社區衛生服務新模式. 衛生經濟研究. 2006, (6): 15-16.
    • 倪靜雲, 卞鷹, 王一濤. 項目管理在中藥新藥研發中的應用. 中國藥業. 2006, 15(21): 13-15.
    • 劉豔, 胡元佳, 卞鷹, 王一濤*. 建立中藥市場第三方廠商認證的意義. 華西藥學雜誌. 2006, 21(3): 319-320.
    • 胡元佳, 趙靜, 邵蓉, 卞鷹, 王一濤. 中國內地及港澳臺地區藥事管理研究動態介紹. 藥學教育. 2006, 22(2): 54-57.
    • 官世海, 卞鷹, 王一濤. 澳門人口老齡化的特點及老齡化醫療照顧. 中國全科醫學. 2006, 9(21): 1745-1748.
    • 高崧, 卞鷹, 王一濤. 澳門藥品製劑說明書規範性調查分析. 澳門醫學雜誌. 2006, 6(2): 114-116.
    • 高崧, 卞鷹, 王一濤. 澳門藥品製劑標籤規範性調查分析. 澳門醫學雜誌. 2006, 6(1): 10-12.
    • 趙靜, 李紹平, 史怡然, 卞鷹, 王一濤. 中藥化學對照品產業化發展策略. 中藥研究與信息. 2005, 7(7): 36-38.
    • 張國華, 李紹平, 萬建波, 夏泉, 王一濤. RP-HPLC法測定三七總皂苷注射液中9種皂苷的含量. 安徽醫藥. 2005, 9(9): 664-665.
    • 余華, 薑豔, 李萍, 李紹平, 王一濤. 中藥川貝母定量分析方法研究. 中國中藥雜誌. 2005, 30(8): 572-575.
    • 楊豐慶, 李紹平, 陳瑩, 劉倩青, 王一濤, 董婷霞, 詹華強. 中藥莪術GC-MS指紋圖譜研究. 藥學學報. 2005, 40(11): 1013-1018.
    • 楊豐慶, 李紹平, 陳瑩, 劉倩青, 王一濤, 董婷霞, 詹華強. 不同來源莪術中莪術醇、吉馬酮、莪術二酮GC-MS定量分析. 藥物分析雜誌. 2005, 25(7): 827-830.
    • 蕭浤, 王一濤. 臨床藥學發展趨勢. 澳門醫學雜誌. 2005, 5(2): 113-115.
    • 萬建波, 徐辰, 李紹平, 孔令義, 王一濤*. 葛根異黃酮成分的加壓溶劑提取法研究. 分析化學. 2005, 33(10): 1435-1438. (IF=0.397)
    • 萬建波, 李紹平, 孔令義, 簡家榮, 王一濤*. 卡瓦胡椒質量評價研究概況. 藥學進展. 2005, 29(1): 19-22.
    • 萬建波, 黎暢明, 李紹平, 孔令義, 王一濤*. 加壓溶劑提取與液相色譜-電噴霧質譜聯用技術分析三七中皂苷類成分. 中藥材. 2005, 28(10): 885-890.
    • 史怡然, 趙靜, 王一濤, 卞鷹. 中藥專利保護的難點分析及建議. 中藥研究與信息. 2005, 7(4): 37-40.
    • 史怡然, 王一濤, 卞鷹, 江濱. 中藥現代化的兩大基石——中藥標準化和中藥智慧財產權保護. 中國藥業. 2005, 14(4): 2-3.
    • 史怡然, 王一濤, 卞鷹. 淺談中藥標準化與中藥知識產權保護結合思考的必要性. 中華實用醫藥雜誌. 2005, 5(9): 855-856.
    • 邱嵐, 趙靜, 宋民憲, 卞鷹, 王一濤. 我國發展中藥材期貨可行性探討. 中藥研究與信息. 2005, 7(7): 33-40.
    • 邱嵐, 林江, 趙靜, 王一濤, 卞鷹. 實物期權模型在新藥研發項目上的應用研究. 當代財經. 2005, (11): 137-140.
    • 邱嵐, 卞鷹, 王一濤, 林江. 淺議城鎮農民工的醫療保障. 衛生經濟研究. 2005, (08): 18-19.
    • 邱嵐, 卞鷹, 王一濤, 林江. 對亞健康醫療服務的經濟學思考. 衛生軟科學. 2005, 19(4): 277-279.
    • 倪靜雲, 卞鷹, 王一濤. 我國中成藥發展策略的探討. 中國醫藥技術與市場. 2005, 5(5): 33-35.
    • 倪靜雲, 卞鷹, 王一濤. 淺談中藥國際市場拓展之差異化策略. 中藥研究與信息. 2005, 7(5): 31-34.
    • 里筱竹, 王一濤, 史錄文. 中國化妝品准入制度向備案制轉變的策略研究. 日用化學品科學. 2005, 28(8): 9-12.
    • 胡元佳, 葛子建, 邵蓉, 卞鷹, 王一濤. 中國醫藥產業呼喚產業政策法. 中國藥業. 2005, 14(12): 2-3.
    • 胡林峰, 李紹平, 王一濤. 中藥靶向製劑研究進展. 中國新藥雜誌. 2005, 14(12): 1387-1390.
    • 高崧, 卞鷹, 王一濤. 從中藥標籤、說明書環節談中藥國際化. 中藥研究與信息. 2005, 7(9): 44-46.
    • 高建莉, 禹志領, 李紹平, 王一濤*. 靈芝三萜類成分研究進展. 中國食用菌. 2005, 24(4): 6-11.
    • 余華, 簡家榮, 李萍, 李紹平, 王一濤*. 紅細胞載體一一種新穎的藥物傳輸系統. 中華臨床醫藥. 2004, 5(8): 3-6.
    • 夏泉, 張平, 李紹平, 王一濤. 當歸的藥理作用研究進展. 時珍國醫國藥. 2004, 15(3): 164-166.
    • 王鐵軍, 李紹平, 簡家榮, 王一濤. 苦參堿抗腫瘤作用研究進展. 中國實驗方劑學雜誌. 2004, 10(4): 52-55.
    • 萬建波, 李紹平, 簡家榮, 孔令義, 王一濤*. 加壓溶劑提取-高效薄層掃描法測定三七中皂苷類成分. 中國天然藥物. 2004, 2(4): 215-218.
    • 史錄文, 鄭陳業, 江濱, 王一濤. 藥品價格政策與醫藥產業發展. 中國藥事. 2004, 18(5): 291-292.
    • 史錄文, 胡彬, 江濱, 曹文莊, 王一濤. 美國藥品註冊與新藥創新. 中國藥事. 2004, 18(6): 352-353.
    • 里筱竹, 卞鷹, 王一濤. 我國中草藥化妝品實現國際標準化初探. 日用化學品科學. 2004, 27(12): 556-558.
    • 李鵬, 萬建波, 李紹平, 王一濤*. 三七皂苷類成分的加即溶劑提取法研究. 中國天然藥物. 2004, 2(3): 157-161.
    • 李鵬, 李紹平, 龔元香, 王一濤. 加壓溶劑提取高效液相色譜法測定天然和人工蟲草中的麥角甾醇、核苷及其堿基. 藥學學報. 2004, 39(11): 917-920.
    • 李鵬, 李紹平, 付超美, 簡家榮, 王一濤*. 加壓溶劑提取技術在中藥質量控制中的應用. 中國中藥雜誌. 2004, 29(8): 723-726.
    • 胡元佳, 宋瑞霖, 邵蓉, 王一濤. 國內外藥事法規概況及其發展趨勢. 中國藥師. 2004, 7(11): 890-892.
    • 胡元佳, 卞鷹, 邵蓉, 王一濤. 國內外醫藥產業政策比較. 中國藥業. 2004, 13(5): 9-10.
    • 胡元佳, 卞鷹, 邵蓉, 王一濤. 中國醫藥工業佈局的現狀、問題與對策. 中國科技產業. 2004, (6): 36-38.
    • 胡元佳, 卞鷹, 邵蓉, 王一濤. 中國醫藥製造業的產業組織分析. 軟科學. 2004, 18(6): 28-30.
    • 史錄文, 顧俊, 王一濤. 美國藥品不良反應監管面臨的問題與挑戰. 中國藥事. 2003, 17(8): 481-482.


      聯絡方法

      王一濤教授
      澳門特別行政區,澳門大學,N22座,中華醫藥研究院,1050室
      電話: (853) 8822 4691
      傳真: (853) 2884 1358
      電郵: YTWang@umac.mo

      中華醫藥研究院院長秘書:劉綺雯小姐
      澳門特別行政區,澳門大學,N22座,中華醫藥研究院,1050室
      電話: (853) 8822 4691
      傳真: (853) 2884 1358
      電郵: IManLao@umac.mo

      中藥質量研究國家重點實驗室主任秘書:陳肖家博士
      澳門特別行政區,澳門大學,N22座,中華醫藥研究院,6007室
      傳真: (853) 2884 1358
      電郵: xiaojiachen@umac.mo